ENTRY = Abscisic Acid, (+,-)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscisic Acid, (E,E)-(+-)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscisic Acid, (E,Z)-(+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscisic Acid, (Z,E)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = ELAV (Embryonic Lethal, Abnormal Vision, Drosophila)-Like 2 (Hu Antigen B)|T116|T123|T129|ABX|EQV|NLM (2016)|150202|abbbcdef
ENTRY = 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone|T109|T121|EQV|NLM (1995)|abbde
ENTRY = Prostan-1-oic acid, 16,16-difluoro-11-hydroxy-9,15-dioxo-, (11alpha)-|T109|T121|EQV|NLM (2007)|070530|abbdef
ENTRY = N-(4-(2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid|T109|T121|EQV|NLM (1994)|abbde
ENTRY = Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer|T109|T121|NON|NRW|NLM (1978)|150225|abbcdef
ENTRY = Brimonidine Tartrate, (R-(R*,R*))-Isomer|T109|T121|NON|NRW|NLM (1978)|150225|abbcdef
ENTRY = Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol|T109|T121|NON|EQV|NLM (1987)|150317|abbcdef
ENTRY = 6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine|T109|T121|NON|EQV|NLM (2016)|150317|abbcdef
ENTRY = 1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate|T109|T121|NON|EQV|NLM (1996)|150318|abbcdef
ENTRY = Formoterol Fumarate, ((R*,R*)-(+-))-isomer|T109|T121|NON|EQV|NLM (1976)|150324|abbcdef
ENTRY = Formoterol, ((R*,R*)-(+-))-isomer|T109|T121|NON|NRW|NLM (1976)|150324|abbcdef
ENTRY = HPV L1 Vaccine, Quadrivalent 6,11,16,18|T121|T129|NON|NRW|NLM (2006)|150327|abbcdef
ENTRY = Human Papillomavirus Vaccine L1, Type 6,11,16,18|T121|T129|NON|NRW|NLM (2006)|150327|abbcdef
ENTRY = Insulin, NPH, Human|T116|T121|T125|NON|EQV|NLM (2016)|150330|abbbcdef
ENTRY = 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one|T109|T121|NRW|NLM (1993)|abbde
ENTRY = 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine|T109|T121|NON|NRW|NLM (2005)|150401|abbcdef
ENTRY = Insulin, Gly(A21)-Arg(B31,B32)|T116|T121|NON|EQV|NLM (1997)|150414|abbcdef
ENTRY = Insulin, Glycyl(A21)-Arginyl(B31,B32)|T116|T121|NON|EQV|NLM (1997)|150414|abbcdef
ENTRY = N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide|T109|T121|BRD|NLM (2008)|080110|abbdef
ENTRY = 1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine|T109|T121|BRD|NLM (2001)|010521|abbdef
ENTRY = 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol|T109|T121|BRD|NLM (1991)|abbde
ENTRY = Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt)|T109|T121|NON|EQV|NLM (2004)|040401|abbcdef
ENTRY = 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester|T109|T121|BRD|NLM (2003)|030623|abbdef
ENTRY = 7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide|T109|T121|NON|EQV|NLM (1993)|abbcde
ENTRY = 2-butenedioic acid, (2E)-, dimethyl ester|T109|EQV|NLM (2013)|130329|abdef
ENTRY = 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-|T109|T121|NON|BRD|NLM (2014)|130521|abbcdef
ENTRY = Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate|T109|T121|NON|EQV|NLM (2001)|150521|abbcdef
ENTRY = Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride|T109|T121|NON|EQV|NLM (2004)|040129|abbcdef
ENTRY = 2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester|T114|T121|NON|EQV|NLM (2010)|101107|abbcdef
ENTRY = (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|T109|T121|NON|EQV|NLM (2016)|150624|abbcdef
ENTRY = 1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-|T109|T121|NON|EQV|NLM (2016)|150624|abbcdef
ENTRY = 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1)|T109|T121|NON|EQV|NLM (2011)|110823|abbcdef
ENTRY = Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate|T121|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination|T121|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = (((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester|T109|T121|NON|NRW|NLM (2001)|011029|abbcdef
ENTRY = 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid|T109|T121|NRW|NLM (1992)|abbde
ENTRY = N-(17-(2-(4-isopropylthiazole-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo(13.3.0.04,6)octadec-7-ene-4-carbonyl)(cyclopropyl)sulfonamide|T109|T121|EQV|NLM (2008)|081023|abbdef
ENTRY = Injury, Brain, Traumatic|T037|NON|EQV|NLM (2000)|991108|INJ BRAIN TRAUMATIC|abcdefv
ENTRY = Transporter 1, ATP-Binding Cassette, Sub-Family B (MDR-TAP)|T116|T123|ABX|EQV|NLM (2017)|160108|abbcdef
ENTRY = ATP-Binding Cassette, Sub-Family B, Member 3|T116|T123|NON|EQV|NLM (2017)|160217|abbcdef
ENTRY = Nuclear Receptor Subfamily 1, Group H, Member 2|T116|T192|NON|NRW|NLM (2009)|160223|abbcdef
ENTRY = Nuclear Receptor Subfamily 1, Group H, Member 3|T116|T192|NRW|NLM (2009)|160223|abbdef
ENTRY = 1,4,5-Triphosphate-1,2,4,5-Tetrakisphosphate 5-Phosphatase|T116|T126|NON|NRW|NLM (1987)|160406|abbcdef
ENTRY = Inositol-1,4,5-Trisphosphate 5'-Phosphatase|T116|T126|NON|NRW|NLM (1988)|160406|abbcdef
ENTRY = Inositol-1,4,5-Trisphosphate 5-Phosphatase|T116|T126|NON|NRW|NLM (1988)|160406|abbcdef
ENTRY = Ins(1,4,5)P3 5'-Phosphatase|T116|T126|ABX|NRW|NLM (1988)|160406|abbcdef
ENTRY = Potassium Voltage-Gated Channel, Subfamily H, Member 2|T116|T123|NON|EQV|NLM (2017)|160421|abbcdef
ENTRY = 2,3,7,8-Tetrachlorodibenzo-p-dioxin|T109|NON|NRW|FDA SRS (2014)|UNK (19XX)|820830|abcdeef
ENTRY = Dibenzo(b,e)(1,4)dioxin, 2,3,7,8-tetrachloro-|T109|NON|NRW|NLM (2017)|160504|abcdef
ENTRY = 5(beta)-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol-24S-hydroxylase|T116|T126|NON|NRW|NLM (1999)|abbcde
ENTRY = 2-(Acetyloxy)-N,N,N-trimethylethanaminium|T109|T121|T123|NON|EQV|NLM (1995)|931123|abbbcdef
ENTRY = Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Acidosis, Renal Tubular, Type I|T047|NON|NRW|NLM (1998)|970519|abcdef
ENTRY = Acidosis, Renal Tubular, Type II|T047|NON|NRW|NLM (1998)|970519|abcdef
ENTRY = RTA, Distal Type, Autosomal Dominant|T047|ABX|NRW|OMIM (2013)|ORD (2010)|121212|abcdeef
ENTRY = Renal Tubular Acidosis, Distal, Autosomal Dominant|T047|NON|NRW|NLM (2007)|OMIM (2013)|ORD (2010)|051101|abcdeeef
ENTRY = Renal Tubular Acidosis, Proximal, with Ocular Abnormalities|T047|NON|NRW|NLM (2007)|051101|abcdef
ENTRY = N,N,N',N'-Tetramethyl-3,6-Acridinediamine Hydrochloride|T109|T130|NON|NRW|NLM (2014)|130205|abbcdef
ENTRY = 2,8-Diamino-10-Methylacridinium Chloride Mixture With 2,8-Diaminoacridine|T109|T121|T130|NON|EQV|NLM (2014)|130221|abbbcdef
ENTRY = Acrocephaly, Skull Asymmetry, and Mild Syndactyly|T019|T047|NON|NRW|GHR (2014)|NLM (2012)|OMIM (2013)|ORD (2010)|101222|abbcdeeeef
ENTRY = Adenosine Triphosphatase, Sodium, Potassium|T116|T126|NON|EQV|NLM (1993)|920414|abbcdef
ENTRY = Carbamimidothioic acid, 2-aminoethyl ester, dihydrobromide|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = Aldosterone, (11 beta,17 alpha)-Isomer|T109|T121|T125|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = 16 alpha,17-Dihydroxypregn-4-ene-3,20-dione|T109|T121|NON|EQV|NLM (2007)|060314|abbcdef
ENTRY = 3-Amino-1,2,4-triazole|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|800730|abbcdeef
ENTRY = 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|950405|abbcdeef
ENTRY = Pyridinium, 1-((4-Amino-2-propyl-5-pyrimidinyl)methyl)-2-methyl-, Chloride (1:1)|T109|T121|NON|REL|FDA SRS (2015)|NLM (2014)|130617|abbcdeef
ENTRY = Anemia, Congenital Dyserythropoietic, Type II|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Anemia, Dyserythropoietic Congenital, Type I|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Anemia, Dyserythropoietic Congenital, Type II|T047|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Anemia, Dyserythropoietic Congenital, Type III|T047|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Anemia, Dyserythropoietic, Congenital Type 1|T047|NON|NRW|NLM (2010)|ORD (2010)|090527|abcdeef
ENTRY = Anemia, Dyserythropoietic, Congenital Type 2|T047|NON|NRW|NLM (2010)|ORD (2010)|090527|abcdeef
ENTRY = Anemia, Dyserythropoietic, Congenital, Type I|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Anemia, Dyserythropoietic, Congenital, Type II|T047|NON|NRW|NLM (1991)|900124|abcdef
ENTRY = Anemia, Dyserythropoietic, Congenital, Type III|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Dyserythropoietic Anemia, Congenital, Type I|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Dyserythropoietic Anemia, Congenital, Type II|T047|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Dyserythropoietic Anemia, Congenital, Type III|T047|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Anemia, Hemolytic, Cold Antibody|T047|NON|NRW|NLM (2012)|ORD (2010)|101202|abcdeef
ENTRY = Anemia, Hemolytic Congenital, Nonspherocytic|T047|NON|EQV|UNK (19XX)|790323|ANEMIA HEMOLYTIC CONGEN NONSPHEROCYTIC|abcdefv
ENTRY = Tooth Agenesis, Selective, 1|T019|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = 1,8,9-Anthracenetriol|T109|T121|NON|EQV|UNK (19XX)|800917|abbcdef
ENTRY = Antigens, Differentiation, B Lymphocyte|T129|EQV|NLM (1990)|890224|ANTIGENS DIFFER B LYMPHOCYTE|abdefv
ENTRY = Antigens, Plasma Cell, PC-1|T129|NRW|UNK (19XX)|870515|abdef
ENTRY = Antigens, Differentiation, T Lymphocyte|T116|T129|EQV|NLM (1990)|890224|ANTIGENS DIFFER T LYMPHOCYTE|abbdefv
ENTRY = 5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione|T109|T121|NON|EQV|NLM (1995)|930901|abbcdef
ENTRY = Polyarthritis, Juvenile, Rheumatoid Factor Negative|T047|NON|EQV|NLM (2014)|130422|abcdef
ENTRY = Polyarthritis, Juvenile, Rheumatoid Factor Positive|T047|NON|REL|NLM (2014)|151117|abcdef
ENTRY = Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione|T114|T121|NON|EQV|NLM (1996)|950517|abbcdef
ENTRY = Solute Carrier Family 4, Anion Exchanger, Member 1|T116|T123|NON|EQV|NLM (2014)|130404|abbcdef
ENTRY = Multiple Basal Cell Nevi, Odontogenic Keratocysts, and Skeletal Anomalies|T191|NON|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101214|abcdeeef
ENTRY = DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide|T109|T121|NON|EQV|NLM (1995)|940325|abbcdef
ENTRY = Benzoylarginine Nitroanilide, Monosodium Salt, Monohydrochloride|T116|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer|T109|T121|NON|NRW|NLM (2006)|990818|abbcdef
ENTRY = Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer|T109|T121|NON|NRW|NLM (2006)|990818|abbcdef
ENTRY = Glycoprotein Ib, Platelet, Deficiency Of|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = 6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one|T109|T121|NON|EQV|NLM (1995)|940329|abbcdef
ENTRY = Bilirubin, (4E,15E)-Isomer|T109|T123|NRW|NLM (1999)|990913|abbdef
ENTRY = Biperiden, 1R-(1 alpha,2 alpha(R*),4 alpha)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Biperiden, 1S-(1 alpha,2 alpha(R*),4 alpha)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Brain Diseases, Metabolic, Acquired|T047|NON|NRW|NLM (2000)|991012|BRAIN DIS METAB ACQUIRED|abcdefv
ENTRY = Brain Disorders, Metabolic, Acquired|T047|NON|NRW|NLM (2000)|991012|BRAIN SYNDROME METAB ACQUIRED|abcdefv
ENTRY = Brain Syndrome, Metabolic, Acquired|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Encephalopathy, Metabolic, Acquired|T047|NON|NRW|NLM (2000)|991012|ENCEPH METAB ACQUIRED|abcdefv
ENTRY = Metabolic Diseases, Acquired, Nervous System|T047|NON|BRD|NLM (2000)|991012|METAB DIS ACQUIRED NERVOUS SYSTEM|abcdefv
ENTRY = Metabolic Disorder, Central Nervous System, Acquired|T047|NON|NRW|NLM (2000)|991012|METAB DIS CNS ACQUIRED|abcdefv
ENTRY = Metabolic Disorders, CNS, Acquired|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Brain Neoplasms, Malignant, Primary|T191|NON|NRW|NLM (2000)|991104|BRAIN NEOPL MALIGNANT PRIMARY|abcdefv
ENTRY = Neoplasms, Brain, Benign|T191|NON|NRW|NLM (2000)|991104|NEOPL BRAIN BENIGN|abcdefv
ENTRY = Neoplasms, Brain, Malignant|T191|NON|NRW|NLM (2000)|991104|NEOPL BRAIN MALIGNANT|abcdefv
ENTRY = Neoplasms, Brain, Primary|T191|NON|NRW|NLM (2000)|991104|NEOPL BRAIN PRIMARY|abcdefv
ENTRY = Leukemia, Lymphoblastic, Burkitt-Type|T191|EPO|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphocytic, L3|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = 2,6-Bis(1,1-dimethylethyl)-4-methylphenol|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|950404|abbcdeef
ENTRY = 1,3,7-Trimethylxanthine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|801205|abbcdeef
ENTRY = Calcifediol, (3 alpha,5Z,7E)-Isomer|T109|T127|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcifediol, (3 beta,5E,7E)-Isomer|T109|T127|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide|T109|T131|NON|EQV|FDA SRS (2014)|NLM (1996)|950404|abbcdeef
ENTRY = Cardiomyopathy, Dilated, 1a|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cardiomyopathy, Dilated, Autosomal Recessive|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cardiomyopathy, Dilated, CMD1A|T047|NON|NRW|NLM (2005)|030825|abcdef
ENTRY = Cardiomyopathy, Dilated, LMNA|T047|NON|NRW|NLM (2005)|030825|abcdef
ENTRY = Cardiomyopathy, Dilated, With Conduction Defect 1|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cardiomyopathy, Dilated, with Conduction Deffect1|T047|NON|NRW|NLM (2005)|030825|abcdef
ENTRY = 7-Glucopyranosyl-3,5,6,8-tetrahydroxyl-1-methyl-9,10-dioxoanthracene-2-carboxylic Acid|T109|T130|NON|EQV|NLM (2014)|130213|abbcdef
ENTRY = Amyotrophy, Thenar, Of Carpal Origin|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-|T109|T121|NON|REL|NLM (2001)|000524|abbcdef
ENTRY = 3,3',4',5,7-Flavanpentol|T109|T121|NON|EQV|UNK (19XX)|800319|abbcdef
ENTRY = Ceftriaxone, Disodium Salt, Hemiheptahydrate|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin, (6R-(6alpha,7beta))-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Neoplasms, Cerebellar, Benign|T191|NON|NRW|NLM (2000)|991103|NEOPL CEREBELLAR BENIGN|abcdefv
ENTRY = Neoplasms, Cerebellar, Malignant|T191|NON|NRW|NLM (2000)|991103|NEOPL CEREBELLAR MALIGNANT|abcdefv
ENTRY = Neoplasms, Cerebellar, Primary|T191|NON|NRW|NLM (2000)|991103|NEOPL CEREBELLAR PRIMARY|abcdefv
ENTRY = Cerebral, Left Hemisphere, Infarction|T047|NON|NRW|NLM (2000)|991104|CEREBRAL LEFT HEMISPHERE INFARCT|abcdefv
ENTRY = Cerebral, Right Hemisphere, Infarction|T047|NON|NRW|NLM (2000)|991104|CEREBRAL RIGHT HEMISPHERE INFARCT|abcdefv
ENTRY = Infarction, Cerebral, Left Hemisphere|T047|NON|NRW|NLM (2000)|991104|INFARCT CEREBRAL LEFT HEMISPHERE|abcdefv
ENTRY = Infarction, Cerebral, Right Hemisphere|T047|NON|NRW|NLM (2000)|991104|INFARCT CEREBRAL RIGHT HEMISPHERE|abcdefv
ENTRY = Infarction, Left Hemisphere, Cerebral|T047|NON|NRW|NLM (2000)|991104|INFARCT LEFT HEMISPHERE CEREBRAL|abcdefv
ENTRY = Infarction, Right Hemisphere, Cerebral|T047|NON|NRW|NLM (2000)|991104|INFARCT RIGHT HEMISPHERE CEREBRAL|abcdefv
ENTRY = Left Hemisphere, Infarction, Cerebral|T047|NON|NRW|NLM (2000)|991104|LEFT HEMISPHERE INFARCT CEREBRAL|abcdefv
ENTRY = Right Hemisphere, Infarction, Cerebral|T047|NON|NRW|NLM (2000)|991104|RIGHT HEMISPHERE INFARCT CEREBRAL|abcdefv
ENTRY = Cerebral Palsy, Diplegic, Infantile|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Monoplegic, Infantile|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Quadriplegic, Infantile|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Neoplasms, Ventricular, Brain|T191|NON|EQV|NLM (2000)|991103|NEOPL VENTRICULAR BRAIN|abcdefv
ENTRY = Otorrhea, Cerebrospinal Fluid, Post-Traumatic|T037|NON|NRW|NLM (2000)|991108|OTORRHEA CSF POST TRAUMATIC|abcdefv
ENTRY = Otorrhea, Cerebrospinal Fluid, Spontaneous|T047|NON|NRW|NLM (2000)|991108|OTORRHEA CSF SPONTANEOUS|abcdefv
ENTRY = Otorrhea, Cerebrospinal Fluid, Traumatic|T037|NON|NRW|NLM (2000)|991108|OTORRHEA CSF TRAUMATIC|abcdefv
ENTRY = Otorrhea, Post-Traumatic, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|OTORRHEA POST TRAUMATIC CSF|abcdefv
ENTRY = Otorrhea, Spontaneous, Cerebrospinal Fluid|T047|NON|NRW|NLM (2000)|991108|OTORRHEA SPONTANEOUS CSF|abcdefv
ENTRY = Rhinorrhea, Cerebrospinal Fluid, Post-Traumatic|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA CSF POST TRAUMATIC|abcdefv
ENTRY = Rhinorrhea, Cerebrospinal Fluid, Spontaneous|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA CSF SPONTANEOUS|abcdefv
ENTRY = Rhinorrhea, Cerebrospinal Fluid, Traumatic|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA CSF TRAUMATIC|abcdefv
ENTRY = Rhinorrhea, Post-Traumatic, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA POST TRAUMATIC CSF|abcdefv
ENTRY = 2,3-Epoxy-4-oxo-7,10-dodecadienoylamide|T109|T121|T123|NON|EQV|UNK (19XX)|810108|abbbcdef
ENTRY = Charcot-Marie-Tooth Disease, Autosomal Dominant, With Focally Folded Myelin Sheaths, Type 1A|T047|NON|NRW|OMIM (2013)|130614|abcdef
ENTRY = Charcot-Marie-Tooth Disease, Autosomal Dominant, with Focally Folded Myelin Sheaths, Type 1B|T047|EPO|NRW|OMIM (2013)|130614|abcdef
ENTRY = Charcot-Marie-Tooth Disease, Demyelinating, Type 1A|T047|EPO|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101214|abcdeeef
ENTRY = Charcot-Marie-Tooth Disease, Demyelinating, Type 1B|T047|EPO|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101228|abcdeeef
ENTRY = Charcot-Marie-Tooth Disease, Slow Nerve Conduction Type, Linked To Duffy|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = 2,3,5,6-Tetrachloro-1,4-benzoquinone|T109|T131|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = Chlormadinone Acetate, (9 beta,10 alpha)-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = (3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|T109|T127|NON|EQV|NLM (1998)|961115|abbcdef
ENTRY = 2-Hydroxy-N,N,N-trimethylethanaminium|T109|T123|NON|EQV|FDA SRS (2014)|NLM (1996)|950404|abbcdeef
ENTRY = Chromosomes, Human, 21 22|T026|NON|NRW|UNK (19XX)|780126|abcdef
ENTRY = Chromosomes, Human, 21-22|T026|NON|NRW|NLM (1968)|990101|abcdef
ENTRY = Chromosomes, Human, 6-12|T026|NON|NRW|NLM (1968)|990101|abcdef
ENTRY = Leucovorin, Calcium (1:1) Salt, (DL)-Isomer|T109|T121|T127|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Leucovorin, Calcium (1:1) Salt, Pentahydrate|T109|T121|T127|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine|T109|T121|T130|NON|EQV|NLM (1995)|940112|abbbcdef
ENTRY = 3,5-Dichloro-2,6-dimethyl-4-pyridinol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|810305|abbcdeef
ENTRY = Coloboma Of Iris, Choroid, And Retina|T019|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Contraceptive Agents, Female, Combined|T121|NON|EQV|NLM (1979)|911021|abcdef
ENTRY = Contraceptive Agents, Oral, Hormonal|T121|NON|EQV|NLM (1992)|911105|abcdef
ENTRY = Contraceptive Agents, Oral, Sequential|T121|NON|EQV|NLM (1992)|911105|abcdef
ENTRY = Contraceptive Agents, Postcoital, Synthetic|T121|NON|EQV|NLM (1992)|911105|CONTRACEPTIVE AGENTS POSTCOITAL SYN|abcdefv
ENTRY = Seizure, Febrile, Complex|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Seizure, Febrile, Simple|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Neoplasms, Cranial Nerve, Benign|T191|NON|NRW|NLM (2000)|991103|NEOPL CRANIAL NERVE BENIGN|abcdefv
ENTRY = Neoplasms, Cranial Nerve, Malignant|T191|NON|NRW|NLM (2000)|991103|NEOPL CRANIAL NERVE MALIGNANT|abcdefv
ENTRY = Tumors, Cranial Nerve, Benign|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Tumors, Cranial Nerve, Malignant|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cyclamate, Calcium (2:1) Salt, Dihydrate|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Hydrocephalus, Internal, Dandy-Walker Type|T047|NON|EQV|GHR (2014)|130418|abcdef
ENTRY = Hydrocephalus, Noncommunicating, Dandy-Walker Type|T047|NON|EQV|GHR (2014)|130418|abcdef
ENTRY = 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene|T109|T131|NON|EQV|FDA SRS (2014)|NLM (2014)|130619|abbcdeef
ENTRY = 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane|T109|T131|NON|EQV|FDA SRS (2014)|NLM (2009)|070730|abbcdeef
ENTRY = DEET, 2,5-di-Me-Analog|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = N,N-Diethyl-2,5-dimethylbenzamide|T109|T121|NON|REL|NLM (1992)|910423|abbcdef
ENTRY = (5beta)-3,7,12-Trioxocholan-24-oic Acid|T109|T121|T130|NON|EQV|NLM (1996)|950406|abbbcdef
ENTRY = Occlusion, Dental, Traumatic|T037|NON|EQV|NLM (1991)|900212|OCCLUSION DENT TRAUMATIC|abcdefv
ENTRY = Deoxycholic Acid, Sodium Salt, 12beta-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Diabetes Mellitus, Insulin-Dependent, 1|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = 1,2,5,6-Dianhydrogalactitol|T109|T121|NON|EQV|UNK (19XX)|820830|abbcdef
ENTRY = Watery Diarrhea, Hypokalemia, and Achlorhydria Syndrome|T047|NON|REL|ORD (2010)|130402|abcdef
ENTRY = 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1995)|930902|abbcdeef
ENTRY = 3,5-Dicarbethoxy-1,4-Dihydrocollidine|T109|NON|EQV|UNK (19XX)|801120|abcdef
ENTRY = 3,5-Diethoxycarbonyl-1,4-Dihydro-2,4,6-Trimethylpyridine|T109|NON|EQV|UNK (19XX)|820331|abcdef
ENTRY = Dicloxacillin, Monosodium Salt, Anhydrous|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Dicloxacillin, Monosodium Salt, Mono-Hydrate|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Dienestrol, (E,E)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Dienestrol, (Z,E)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Dienestrol, (Z,Z)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Ditiocarb, Sodium Salt, Trihydrate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cholestanol, (3alpha, 5beta)-Isomer|T109|T123|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Butanedioic Acid, 2,3-Dimercapto-, (R*,S*)-Isomer|T109|T121|T130|NON|EQV|NLM (2014)|130625|abbbcdef
ENTRY = Succimer Antimony Sodium Salt, (R*,S*)-Isomer|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Succimer, (R*,R*)-(+,-)-Isomer|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = 5,5-Dimethyl-2,4-oxazolidinedione|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|800731|abbcdeef
ENTRY = 5,5-Dimethyloxazolidine-2,4-dione|T109|T121|NON|EQV|UNK (19XX)|811026|abbcdef
ENTRY = 1,6-Diphenyl-1,3,5-hexatriene|T109|T130|NON|EQV|UNK (19XX)|820519|abbcdef
ENTRY = Disopyramide, D-Tartrate (1:1), (S)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Disopyramide, L-Tartrate (1:1), (R)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Disopyramide, L-Tartrate (1:1), (S)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Disopyramide, L-Tartrate (1:2), (+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Disopyramide, L-Tartrate, (S)-isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,3-Dihydroxy-1,4-dithiolbutane|T109|T130|NON|BRD|UNK (19XX)|861001|abbcdef
ENTRY = 3-(3,4-Dichlorophenyl)-1,1-dimethylurea|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|810427|abbcdeef
ENTRY = Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer)|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer)|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,5-Dimethoxy-4-Methylamphetamine Hydrochloride, (+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,5-Dimethoxy-4-Methylamphetamine Hydrochloride, (R)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,5-Dimethoxy-4-Methylamphetamine Hydrochloride, (S)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,5-Dimethoxy-4-Methylamphetamine, (+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,5-Dimethoxy-4-Methylamphetamine, (R)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,5-Dimethoxy-4-Methylamphetamine, (S)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,5-Dimethoxy-4-Methylamphetamine, Hydrochloride|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 47,XX,+21|T019|NON|EQV|GHR (2014)|130614|abcdef
ENTRY = 47,XY,+21|T019|NON|EQV|GHR (2014)|130614|abcdef
ENTRY = Evaluation Studies, Drug, Preclinical|T062|NON|EQV|UNK (19XX)|840501|EVALUATION STUDIES DRUG PRECLIN|abcdefv
ENTRY = Hereditary Sensory Neuropathy, Dominant, Type 3|T019|T047|NON|EQV|NLM (2000)|991108|abbcdef
ENTRY = Hereditary Sensory Neuropathy, Dominant, Type III|T019|T047|NON|EQV|NLM (2000)|991108|abbcdef
ENTRY = Hereditary Sensory Neuropathy, Type 3, Dominant|T019|T047|NON|EQV|NLM (2000)|991108|abbcdef
ENTRY = Neuropathy, Hereditary Sensory And Autonomic, Type III|T019|T047|NON|EQV|OMIM (2013)|160623|abbcdef
ENTRY = 2-((Diethoxyphosphinyl)thio)-N,N,N,-trimethylethanaminium iodide|T109|T121|NON|EQV|NLM (1995)|940324|abbcdef
ENTRY = Ectodermal Dysplasia, Hidrotic, Autosomal Dominant|T019|T047|NON|NRW|OMIM (2013)|111115|abbcdef
ENTRY = Edetic Acid, Calcium, Sodium Salt|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Edetic Acid, Disodium Salt, Dihydrate|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Edetic Acid, Disodium, Magnesium Salt|T109|T121|T130|NON|NRW|NLM (2001)|000517|abbbcdef
ENTRY = Edetic Acid, Disodium, Monopotassium Salt|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine)|T109|T121|T130|NON|EQV|NLM (1999)|970811|abbbcdef
ENTRY = Education, Pharmaceutic, Continuing|T065|NON|EQV|NLM (1994)|930122|abcdef
ENTRY = Education, Pharmaceutical, Continuing|T065|NON|EQV|UNK (19XX)|790419|abcdef
ENTRY = Education, Pharmaceutic, Graduate|T065|NON|EQV|NLM (1994)|930122|abcdef
ENTRY = Education, Pharmaceutical, Graduate|T065|NON|EQV|UNK (19XX)|790419|abcdef
ENTRY = Glycoletherdiamine-N,N,N',N'-tetraacetic Acid|T109|T130|NON|EQV|NLM (1998)|961114|abbcdef
ENTRY = Ehlers-Danlos Syndrome, Type IV, Autosomal Dominant|T019|T047|EPO|NRW|OMIM (2013)|120621|abbcdef
ENTRY = Spectrometry, X Ray Emission, Electron Microscopic|T059|NON|EQV|UNK (19XX)|840502|abcdef
ENTRY = Spectrometry, X Ray Emission, Electron Probe|T059|NON|EQV|UNK (19XX)|840502|abcdef
ENTRY = Encephalitis, California, Viral|T047|NON|EQV|NLM (2000)|991103|ENCEPH CALIFORNIA VIRAL|abcdefv
ENTRY = Encephalitis, Viral, St. Louis|T047|EPO|EQV|NLM (2000)|991103|ENCEPH VIRAL ST LOUIS|abcdefv
ENTRY = Environmental Pollutants, Noxae, and Pesticides|T131|NON|NRW|NLM (1974)|990101|abcdef
ENTRY = Eosine Yellowish-(YS), Potassium, Sodium Salt|T109|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Partial Seizures, Simple, Consciousness Preserved|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Seizure Disorder, Convulsive, Generalized|T047|NON|NRW|NLM (2000)|991109|SEIZURE DIS CONVULSIVE GENERALIZED|abcdefv
ENTRY = Seizure Disorder, Generalized, Convulsive|T047|NON|NRW|NLM (2000)|991109|SEIZURE DIS GENERALIZED CONVULSIVE|abcdefv
ENTRY = Epilepsy, Tonic-Clonic, Cryptogenic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Epilepsy, Tonic-Clonic, Familial|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Epilepsy, Tonic-Clonic, Symptomatic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Epilepsy, Early Childhood, Myoclonic|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Epilepsy, Myoclonic, Early Childhood|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Epilepsy, Myoclonic, Infantile|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Epilepsy, Myoclonic, Infantile, Benign|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Epilepsy, Myoclonic, Infantile, Severe|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Myoclonic Epilepsy, Infantile, Benign|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Myoclonic Epilepsy, Infantile, Severe|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Myoclonic Epilepsy, Severe, Of Infancy|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Epilepsy, Absence, Atypical|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Ergotoxin, Dihydro-, Monomethasulfonate|T109|T121|NON|EQV|NLM (2001)|000516|abbcdef
ENTRY = 2',4',5',7'-Tetraiodofluorescein|T109|T130|NON|EQV|NLM (2003)|011212|abbcdef
ENTRY = Estradiol, (16 alpha,17 alpha)-Isomer|T109|T121|T125|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = Estradiol, (16 alpha,17 beta)-Isomer|T109|T121|T125|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = Estradiol, (8 alpha,17 beta)-(+-)-Isomer|T109|T121|T125|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = Estradiol, (8 alpha,17 beta)-Isomer|T109|T121|T125|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = Estradiol, (9 beta,17 alpha)-Isomer|T109|T121|T125|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = Estradiol, (9 beta,17 beta)-Isomer|T109|T121|T125|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol|T109|T121|T125|NON|EQV|NLM (2014)|130318|abbbcdef
ENTRY = (16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol|T109|NON|REL|NLM (2014)|130318|abcdef
ENTRY = Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol|T109|NON|REL|NLM (2014)|130318|abcdef
ENTRY = Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ethinyl Estradiol, (9 beta,17 alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 1,2-Dihydro-6-Ethoxy-2,2,4-Trimethylquinoline|T109|T121|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|820830|abbbcdeef
ENTRY = 6-ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline|T109|T121|T130|NON|EQV|NLM (2009)|abbbcde
ENTRY = Ethylmorphine Hydrochloride, (5alpha,6alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ethylmorphine Hydrochloride, Dihydrate, (5alpha,6alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ethylmorphine Sulfate (2:1), (5alpha,6alpha)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Ethylmorphine, (5alpha,6beta)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Novartis Brand of Ethylmorphine Hydrochloride, (5alpha,6alpha)-Isomer|T109|T121|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = (3 beta, 17 alpha)-19-Norpregn-4-en-20-yne-3,17 diol Diacetate|T109|T121|NON|EQV|NLM (1998)|970127|abbcdef
ENTRY = Etoposide, (5a alpha,9 alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Exostoses, Multiple, Type I|T019|T191|NON|EQV|OMIM (2013)|111115|abbcdef
ENTRY = Healthcare Facilities, Manpower, and Services|T078|NON|EQV|NLM (1998)|970110|abcdef
ENTRY = Fenoprofen, Anhydrous, Calcium Salt|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ferrozine, Monosodium Salt, Monohydrate|T109|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl|T109|T121|NON|EQV|NLM (2014)|130226|abbcdef
ENTRY = Mental Retardation, X-Linked, Associated With Fragile Site Fraxe|T019|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Mental Retardation, X-Linked, Associated With Marxq28|T019|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Fructose 1,6-Bisphosphate Aldolase, Class II|T116|T126|NON|EQV|NLM (1990)|890607|FRUCTOSE 1 6 BISPHOSPHATE ALDOLASE CLASS II|abbcdefv
ENTRY = 3,4,5-Trihydroxybenzoic Acid|T109|T130|NON|EQV|FDA SRS (2014)|NLM (1999)|980112|abbcdeef
ENTRY = Gaucher Disease, Juvenile and Adult, Cerebral|T047|EPO|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101209|abcdeeef
ENTRY = Glomus Tumors, Familial, 1|T191|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = 1,2,3-Trihydroxypropane|T109|T121|T123|NON|EQV|UNK (19XX)|840918|abbbcdef
ENTRY = Deficiency Disease, Lysosomal alpha-1,4-Glucosidase|T047|NON|EQV|NLM (2000)|991103|DEFIC DIS LYSOSOMAL ALPHA 1 4 GLUCOSIDASE|abcdefv
ENTRY = Aurothioglucose, Sodium Salt, beta-D Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Complete Gonadal Dysgenesis, 46, XY|T019|T047|NON|NRW|NLM (2011)|100202|abbcdef
ENTRY = Gonadal Dysgenesis, 46, XY|T019|T047|NON|EQV|UNK (19XX)|781221|abbcdef
ENTRY = Pure Gonadal Dysgenesis, 46, XY|T019|T047|NON|NRW|NLM (2011)|100202|abbcdef
ENTRY = Sex Reversal, Gonadal, 46, XY|T019|T047|NON|EQV|NLM (2011)|100202|abbcdef
ENTRY = Cytochrome B-Negative Granulomatous Disease, Chronic, X-Linked|T047|BRD|OMIM (2013)|111115|abdef
ENTRY = Cytochrome B-Positive Granulomatous Disease, Chronic, X-Linked|T047|BRD|OMIM (2013)|111115|abdef
ENTRY = Granulomatous Disease, Chronic, X-Linked|T047|BRD|OMIM (2013)|111115|abdef
ENTRY = Granulomatous Disease, Chronic, X-Linked, Variant|T047|BRD|OMIM (2013)|111115|abdef
ENTRY = Hair Cell, Auditory, Inner|T025|NON|EQV|NLM (2012)|110317|abcdef
ENTRY = Hallucinations, Formed, of People|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Hallucinations, Visual, Formed|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Hallucinations, Visual, Unformed|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = 1,1,1-Trifluoro-2-Chloro-2-Bromoethane|T109|T121|NON|EQV|UNK (19XX)|810713|abbcdef
ENTRY = Macrocephaly, Multiple Lipomas, and Hemangiomata|T191|NON|REL|NLM (2012)|OMIM (2013)|ORD (2010)|101228|abcdeeef
ENTRY = Macrocephaly, Pseudopapilledema, and Multiple Hemangiomas|T191|NON|REL|NLM (2012)|ORD (2010)|101228|abcdeef
ENTRY = Macrocephaly, Pseudopapilledema, and Multiple Hemangiomata|T191|NON|REL|OMIM (2013)|130403|abcdef
ENTRY = Hand, Foot, Mouth Disease|T047|NON|EQV|NLM (1990)|891011|abcdef
ENTRY = Health Insurance for Aged, Disabled, Title 18|T089|NON|EQV|UNK (19XX)|790329|HEALTH INSURANCE AGED DISABLED TITLE 18|abcdefv
ENTRY = Hematoma, Epidural, Intracranial|T020|T037|NON|EQV|NLM (2005)|031028|abbcdef
ENTRY = 1,5-Dimethyl-1,5-Diazaundecamethylene Polymethobromide|T109|T121|NON|EQV|UNK (19XX)|861003|abbcdef
ENTRY = Hexestrol, (R*,R*)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Hexestrol, (R*,S*)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Hexestrol, (R-(R*,R*))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Hexestrol, (S-(R*,R*))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Hip Dysplasia, Congenital, Nonsyndromic|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Hip, Dislocation Of, Congenital|T019|T047|NON|EQV|OMIM (2013)|111115|abbcdef
ENTRY = 4-(5-(4-Methyl-1-piperazinyl)(2,5'-bi-1H-benzimidazol)-2'-yl)phenol, trihydrochloride|T109|T121|T130|NON|NRW|NLM (2009)|080703|abbbcdef
ENTRY = Hospitals, City, Public Owned|T073|T093|NON|EQV|UNK (19XX)|880430|abbcdef
ENTRY = Progressive Chorea, Hereditary, Chronic (Huntington)|T047|EPO|EQV|NLM (2000)|991103|abcdef
ENTRY = Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer|T109|T121|T125|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = (2S,5R)-2,6-Diamino-5-hydroxyhexanoic Acid|T116|T123|NON|EQV|NLM (2017)|160519|abbcdef
ENTRY = 17-Hydroxypregnenolone, (3beta,13alpha)-Isomer|T109|T123|NON|NRW|NLM (2004)|990818|abbcdef
ENTRY = 17-Hydroxypregnenolone, (3beta,13alpha,17alpha)-Isomer|T109|T123|NON|NRW|NLM (2004)|990818|abbcdef
ENTRY = 17-Hydroxypregnenolone, (3beta,17alpha)-Isomer|T109|T123|NON|EQV|NLM (2004)|990818|abbcdef
ENTRY = Hypercholesterolemia, Autosomal Dominant, Type B|T047|NON|NRW|NLM (2010)|OMIM (2013)|ORD (2010)|090513|abcdeeef
ENTRY = Neoplasms, Hypothalamic, Benign|T191|NON|NRW|NLM (2000)|991103|NEOPL HYPOTHALAMIC BENIGN|abcdefv
ENTRY = Neoplasms, Hypothalamic, Malignant|T191|NON|NRW|NLM (2000)|991103|NEOPL HYPOTHALAMIC MALIGNANT|abcdefv
ENTRY = (delta-2,2'-biindole)-3,3'-dione|T109|T130|NON|REL|NLM (1969)|abbcde
ENTRY = Iopamidol, Sodium Salt, (S)-Isomer|T109|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Iothalamic Acid, Monosodium Salt, Dimer|T109|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ciliary Dyskinesia, Primary, 1|T019|T047|NON|EQV|OMIM (2013)|111115|abbcdef
ENTRY = Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus|T019|T047|NON|EQV|OMIM (2013)|111115|abbcdef
ENTRY = Dextrocardia, Bronchiectasis, and Sinusitis|T019|T047|NON|EQV|NL|NLM (2012)|OMIM (2013)|101206|abbcdeeef
ENTRY = Ophthalmoplegia, Pigmentary Degeneration of Retina, and Cardiomyopathy|T047|NON|EQV|NLM (2010)|OMIM (2013)|ORD (2010)|090521|abcdeeef
ENTRY = Ophthalmoplegia, Progressive External, With Ragged-Red Fibers|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione|T109|T121|NON|EQV|NLM (1995)|940324|abbcdef
ENTRY = 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one|T109|T121|NON|EQV|NLM (1995)|940323|abbcdef
ENTRY = Knowledge, Attitudes, Practice|T041|T054|T055|NON|EQV|BIOETHICS (1998)|NLM (1975)|990101|abbbcdeef
ENTRY = Labetalol, (R,R)-Isomer|T109|T121|NON|NRW|NLM (2011)|100309|abbcdef
ENTRY = 4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol|T109|T123|NON|EQV|UNK (19XX)|831014|abbcdef
ENTRY = Encephalopathy, Subacute Necrotizing, Infantile|T047|NON|NRW|NLM (2000)|991104|ENCEPH SUBACUTE NECROTIZING INFANTILE|abcdefv
ENTRY = Encephalopathy, Subacute Necrotizing, Juvenile|T047|NON|NRW|NLM (2000)|991104|ENCEPH SUBACUTE NECROTIZING JUVENILE|abcdefv
ENTRY = Juvenile Gout, Choreoathetosis, Mental Retardation Syndrome|T047|NON|EQV|NLM (2014)|130418|abcdef
ENTRY = Leukemia, Myeloid, Schilling Type|T191|EPO|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Monocytic, Chronic|T033|T191|NON|REL|NLM (1989)|990101|abbcdef
ENTRY = Leukodystrophy, Globoid Cell, Classic|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Leukodystrophy, Globoid Cell, Early-Onset|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Leukodystrophy, Globoid Cell, Infantile|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Leukodystrophy, Globoid Cell, Late-Onset|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Cerebral sclerosis, Diffuse, Metachromatic Form|T047|NON|EQV|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090518|abcdeeeef
ENTRY = Leukodystrophy, Metachromatic, Adult|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Leukodystrophy, Metachromatic, Juvenile|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Hyperlipemia, Idiopathic, Burger-Grutz Type|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Biliary Cirrhosis, Primary, 1|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine|T109|T121|NON|EQV|NLM (1995)|930909|abbcdef
ENTRY = Lymphedema, Hereditary, Ia|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Lymphocytic Lymphoma, Nodular, Poorly Differentiated|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphocytic Lymphoma, Nodular, Poorly-Differentiated|T191|NON|NRW|NLM (1991)|900514|LYMPHOCYTIC LYMPHOMA NODULAR POORLY DIFFER|abcdefv
ENTRY = Lymphoma, Follicular, Grade 1|T191|NON|NRW|NLM (2008)|061018|abcdef
ENTRY = Lymphoma, Follicular, Grade 2|T191|NON|NRW|NLM (2008)|061018|abcdef
ENTRY = Lymphoma, Follicular, Grade 3|T191|NON|NRW|NLM (2008)|061018|abcdef
ENTRY = Lymphoma, Follicular, Mixed Cell|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA FOLLIC MIXED|abcdefv
ENTRY = Lymphoma, Follicular, Mixed Lymphocytic-Histiocytic|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA FOLLIC MIXED LYMPHOCYTIC HISTIOCYTIC|abcdefv
ENTRY = Lymphoma, Follicular, Mixed Small and Large Lymphoid|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA FOLLIC MIXED SMALL LARGE LYMPHOID|abcdefv
ENTRY = Lymphoma, Follicular, Small and Large Cleaved Cell|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Follicular, Small and Large Cleaved-Cell|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA FOLLIC SMALL LARGE CLEAVED|abcdefv
ENTRY = Lymphoma, Histiocytic, Nodular|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Large Cell, Follicular|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Large Lymphoid, Nodular|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Large-Cell, Follicular|T191|NON|NRW|NLM (1991)|990101|LYMPHOMA LARGE FOLLIC|abcdefv
ENTRY = Lymphoma, Lymphocytic, Nodular, Poorly Differentiated|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Lymphocytic, Nodular, Poorly-Differentiated|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA LYMPHOCYTIC NODULAR POORLY DIFFER|abcdefv
ENTRY = Lymphoma, Mixed-Cell, Follicular|T191|NON|NRW|NLM (1991)|990101|LYMPHOMA MIXED FOLLIC|abcdefv
ENTRY = Lymphoma, Nodular, Large Follicular Center Cell|T191|NON|NRW|NLM (1991)|900524|abcdef
ENTRY = Lymphoma, Nodular, Large Follicular Center-Cell|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA NODULAR LARGE FOLLIC CENTER|abcdefv
ENTRY = Lymphoma, Nodular, Mixed Lymphocytic Histiocytic|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Nodular, Mixed Lymphocytic-Histiocytic|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Nodular, Mixed Small and Large Cell|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA NODULAR MIXED SMALL LARGE|abcdefv
ENTRY = Lymphoma, Small Cleaved Cell, Follicular|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA SMALL CLEAVED CELL FOLLIC|abcdefv
ENTRY = Lymphoma, Small Cleaved-Cell, Follicular|T191|NON|NRW|NLM (1991)|990101|LYMPHOMA SMALL CLEAVED FOLLIC|abcdefv
ENTRY = Lymphoma, Small Lymphoid, Follicular|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA SMALL LYMPHOID FOLLIC|abcdefv
ENTRY = Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA DIFFUSE MIXED LYMPHOCYTIC HISTIOCYTIC|abcdefv
ENTRY = Lymphoma, Mixed Cell, Diffuse|T191|NON|NRW|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Mixed Small and Large Cell, Diffuse|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA MIXED SMALL LARGE DIFFUSE|abcdefv
ENTRY = Lymphoma, Mixed-Cell, Diffuse|T191|NON|NRW|NLM (1991)|990101|LYMPHOMA MIXED DIFFUSE|abcdefv
ENTRY = Lymphoma, Non-Hodgkin, Familial|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Lymphoma, Small Cleaved Cell, Diffuse|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Small Cleaved-Cell, Diffuse|T191|NON|EQV|NLM (1991)|990101|LYMPHOMA SMALL CLEAVED DIFFUSE|abcdefv
ENTRY = Lymphoma, Small and Large Cleaved-Cell, Diffuse|T191|NON|NRW|NLM (1991)|900514|LYMPHOMA SMALL LARGE CLEAVED DIFFUSE|abcdefv
ENTRY = Lymphoma, Undifferentiated, Diffuse|T191|NON|NRW|NLM (1991)|900513|LYMPHOMA UNDIFFER DIFFUSE|abcdefv
ENTRY = Lymphoproliferative Syndrome, X-Linked, 1|T047|NON|NRW|GHR (2014)|111115|abcdef
ENTRY = Lynestrenol, (9 beta, 10 alpha,17 alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Lymphoma, Lymphocytic, Plasmacytoid|T191|NON|EQV|NLM (1991)|900513|abcdef
ENTRY = Malocclusion, Angle Class II, Division 1|T047|NON|NRW|NLM (2017)|151221|abcdef
ENTRY = Malocclusion, Angle Class II, Division 2|T047|NON|NRW|NLM (2017)|151221|abcdef
ENTRY = Medicine, Traditional, East Asia|T058|NON|EQV|NLM (2009)|080314|abcdef
ENTRY = Cheilitis Granulomatosa, Orofacial Edema, Facial Neuropathy|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Facial Neuropathy, Cheilitis Granulomatosa, Orofacial Edema|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Facial Neuropathy, Orofacial Edema, Cheilitis Granulomatosa|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Macrocheilia, Facial Palsy, Edema|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Orofacial Edema, Cheilitis Granulomatosa, Facial Neuropathy|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Orofacial Edema, Facial Neuropathy, Cheilitis Granulomatosa|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Meningitis, Hemophilus influenzae, Type B|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Meningitis, Meningococcal, Serogroup A|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Meningitis, Meningococcal, Serogroup B|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Meningitis, Meningococcal, Serogroup C|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Meningitis, Meningococcal, Serogroup W-135|T047|NON|NRW|NLM (2003)|020227|abcdef
ENTRY = Meningitis, Meningococcal, Serogroup W135|T047|NON|NRW|NLM (2003)|021018|abcdef
ENTRY = Meningitis, Meningococcal, Serogroup Y|T047|NON|NRW|NLM (2003)|020227|abcdef
ENTRY = Meningitis, Pneumococcal, Experimental|T050|NON|NRW|NLM (2000)|991103|MENINGITIS PNEUMOCOCCAL EXPER|abcdefv
ENTRY = Meningitis, Pneumococcal, Penicillin-Resistant|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Meningitis, Pneumococcal, Recurrent|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Menthol, (1alpha,2beta,5alpha)-Isomer|T109|T121|REL|NLM (1999)|990913|abbdef
ENTRY = 3,4,5-Trimethoxyphenethylamine|T109|T121|T131|NON|EQV|NLM (1998)|970127|abbbcdef
ENTRY = Detoxification, Drug, Metabolic|T040|NON|NRW|UNK (19XX)|800515|abcdef
ENTRY = (3R,6R)-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane|T109|T121|NON|NRW|NLM (2014)|130622|abbcdef
ENTRY = N,N-Dimethyl-N'-2-pyridinyl-N'-(2-thienylmethyl)-1,2-ethanediamine|T109|T121|NON|EQV|NLM (1995)|940323|abbcdef
ENTRY = 3,3'-Dichloro-4,4'-Diaminodiphenylmethane|T109|T131|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = 4-(2-Amino-1-hydroxypropyl)-1,2-benzenediol Hydrochloride, (R*,R*)-(+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 4-(2-Amino-1-hydroxypropyl)-1,2-benzenediol Hydrochloride, (R*,S*)-(+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 4-(2-Amino-1-hydroxypropyl)-1,2-benzenediol Tartrate, (R*,R*), (R*,R*)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 4-(2-Amino-1-hydroxypropyl)-1,2-benzenediol Tartrate, (R*,S*), (R*,R*)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 4-(2-Amino-1-hydroxypropyl)-1,2-benzenediol, (R*,R*)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = 4-(2-Amino-1-hydroxypropyl)-1,2-benzenediol, (R*,S*)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Nordefrin Hydrochloride, (R*,R*)-(+,-)-Isomer|T109|T121|NON|NRW|NLM (2001)|000525|abbcdef
ENTRY = Nordefrin Hydrochloride, (R*,S*)-(+,-)-Isomer|T109|T121|NON|NRW|NLM (2001)|000525|abbcdef
ENTRY = Nordefrin Tartrate, (R*,R*), (R*,R*) Isomer|T109|T121|NON|NRW|NLM (2001)|000525|abbcdef
ENTRY = Nordefrin Tartrate, (R*,S*), (R*,R*) Isomer|T109|T121|NON|NRW|NLM (2001)|000525|abbcdef
ENTRY = Nordefrin, (R*,R*)-Isomer|T109|T121|NON|REL|NLM (2001)|000525|abbcdef
ENTRY = Nordefrin, (R*,S*)-Isomer|T109|T121|NON|REL|NLM (2001)|000525|abbcdef
ENTRY = Mouse, Founder, Transgenic|T015|NON|NRW|NLM (2005)|040330|abcdef
ENTRY = Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Amyotrophy, Neurogenic Scapuloperoneal, New England Type|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Ipratropium Bromide, (endo,anti)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ipratropium Bromide, (exo,syn)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Nafcillin, Monosodium Salt, Anhydrous|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abnormalities, Congenital, Nervous System|T019|T047|NON|EQV|NLM (2000)|991108|ABNORM CONGEN NERVOUS SYSTEM|abbcdefv
ENTRY = Malformations, Nervous System, Congenital|T019|T047|NON|EQV|NLM (2000)|991108|MALFORMATIONS NERVOUS SYSTEM CONGEN|abbcdefv
ENTRY = Neurofibromatosis, Peripheral, NF 1|T047|EQV|UNK (19XX)|880608|abdef
ENTRY = Neurofibromatosis, Peripheral, NF1|T047|EQV|UNK (19XX)|880608|abdef
ENTRY = Neuroma, Acoustic, Unilateral|T191|NON|NRW|NLM (1993)|911218|abcdef
ENTRY = Ceroid Lipofuscinosis, Neuronal 3, Juvenile|T047|NON|NRW|ORD (2010)|121212|abcdef
ENTRY = Ceroid Lipofuscinosis, Neuronal, 3|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Ceroid Lipofuscinosis, Neuronal, 4A, Autosomal Recessive|T047|NON|NRW|OMIM (2013)|120629|abcdef
ENTRY = Ceroid Lipofuscinosis, Neuronal, 4B, Autosomal Dominant|T047|NON|NRW|OMIM (2013)|120716|abcdef
ENTRY = Ceroid Lipofuscinosis, Neuronal, Parry Type|T047|EPO|NRW|OMIM (2013)|111115|abcdef
ENTRY = Insensitivity to Pain, Congenital, with Anhidrosis|T047|NON|NRW|NLM (2010)|OMIM (2013)|ORD (2010)|090513|abcdeeef
ENTRY = Neuropathy, Congenital Sensory, with Anhidrosis|T047|NON|NRW|NLM (2010)|OMIM (2013)|ORD (2010)|090513|abcdeeef
ENTRY = Neuropathy, Hereditary Sensory And Autonomic, Type I|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Neuropathy, Hereditary Sensory And Autonomic, Type V|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Neuropathy, Hereditary Sensory Radicular, Autosomal Dominant|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Neuropathy, Hereditary Sensory Radicular, Autosomal Recessive|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Neuropathy, Hereditary Sensory, Type I|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Neuropathy, Progressive Sensory, Of Children|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Nitroprusside, Disodium Salt, Dihydrate|T121|T130|T197|NRW|NLM (1999)|990913|abbbdef
ENTRY = (R*,S*)-4,4'-(2,3-Dimethylbutane-1,4-diyl)bispyrocatechol|T109|T121|NON|EQV|NLM (2014)|130206|abbcdef
ENTRY = Nordihydroguaiaretic Acid, (R*,S*)-Isomer|T109|T121|EQV|NLM (1999)|990913|abbdef
ENTRY = Norepinephrine Hydrochloride, (+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Norepinephrine l-Tartrate (1:1), (+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Norepinephrine, (+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Obstetrics, Gynecology Department, Hospital|T093|NON|EQV|UNK (19XX)|790329|OBSTETRICS GYNECOL DEP HOSP|abcdefv
ENTRY = Hypertrophic Osteoarthropathy, Primary, Autosomal Dominant|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Myotonic Myopathy, Dwarfism, Chondrodystrophy, And Ocular And Facial Abnormalities|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Osteopetrosis, Autosomal Dominant, Type II|T047|NON|NRW|OMIM (2013)|120627|abcdef
ENTRY = Oxacillin, Monosodium Salt, Anhydrous|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Oxacillin, Monosodium Salt, Monohydrate|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Oxymetholone, (5 alpha,17 alpha)-Isomer|T109|T121|T125|NRW|NLM (1999)|990913|abbbdef
ENTRY = Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Oxytetracycline, Disodium Salt, Dihydrate|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = p-Aminosalicylic Acid, Monosodium Salt, Dihydrate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Paragangliomas, Familial, 1|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Paragangliomas, Familial Nonchromaffin, 1|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Bulbar Palsy, Progressive, Of Childhood|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Ovoid Neutrophil Nuclei, Developmental Delay, Epilepsy and Skeletal Abnormalities|T047|NON|EQV|NLM (2012)|ORD (2011)|110223|abcdeef
ENTRY = Ovoid Neutrophil Nuclei, Developmental Delay, Epilepsy, and Skeletal Abnormalities|T047|NON|EQV|ORD (2010)|121212|abcdef
ENTRY = Chain Elongation, Peptide, Translational|T044|NON|EQV|NLM (2005)|040330|abcdef
ENTRY = Chain Initiation, Peptide, Translational|T044|NON|EQV|NLM (2005)|040330|abcdef
ENTRY = Chain Termination, Peptide, Translational|T044|NON|EQV|NLM (2005)|040330|abcdef
ENTRY = Periodontitis, Aggressive, 1|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Pulmonary Hypertension, Familial Persistent, of the Newborn|T047|NON|EQV|NLM (2010)|OMIM (2013)|ORD (2010)|090619|abcdeeef
ENTRY = Deficiency Disease, Phenylalanine Hydroxylase, Severe|T047|NON|NRW|NLM (2000)|991105|DEFIC DIS PHENYLALANINE HYDROXYLASE SEVERE|abcdefv
ENTRY = Hyperphenylalaninemia, BH4-Deficient, C|T047|NON|NRW|OMIM (2013)|130503|abcdef
ENTRY = Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency|T047|NON|NRW|OMIM (2013)|130503|abcdef
ENTRY = 1,3,5-Benzenetriol|T109|T121|T130|NON|EQV|NLM (2014)|130111|abbbcdef
ENTRY = Benzene-1,3,5-triol|T109|T121|T130|NON|EQV|NLM (2014)|130111|abbbcdef
ENTRY = 1-Chloro-2,4,6-trinitrobenzene|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|830916|abcdeef
ENTRY = Glossoptosis, Micrognathia, and Cleft Palate|T019|T047|NON|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101209|abbcdeeef
ENTRY = Pilocarpine, Monohydrochloride, (3S-cis)-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer|T109|T121|T131|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer|T109|T121|T131|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer|T109|T121|T131|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Podophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-Isomer|T109|T121|T131|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = 5-beta-Pregnane-3,17,20-triol|T109|NON|EQV|NLM (2004)|030205|abcdef
ENTRY = 5beta-Pregnane-3alpha,17alpha,20alpha-triol|T109|NON|EQV|NLM (2004)|030205|abcdef
ENTRY = Pregnanolone, (3alpha, 5beta, 17-alpha)-isomer|T109|T121|T123|NON|NRW|NLM (2002)|000804|abbbcdef
ENTRY = Pregnanolone, (3alpha,5alpha)-isomer|T109|T121|T123|NON|REL|NLM (2002)|000804|abbbcdef
ENTRY = Pregnanolone, (3alpha,5beta)-isomer|T109|T121|T123|NON|EQV|NLM (2002)|000804|abbbcdef
ENTRY = Pregnanolone, (3beta, 5alpha)-isomer|T109|T121|T123|REL|NLM (1999)|990913|abbbdef
ENTRY = Pregnanolone, (3beta, 5alpha, 17alpha)-isomer|T109|T121|T123|NON|REL|NLM (2002)|000804|abbbcdef
ENTRY = Pregnanolone, (3beta, 5alpha, 8alpha, 17beta)-isomer|T109|T121|T123|NON|REL|NLM (2002)|000804|abbbcdef
ENTRY = Pregnanolone, (3beta, 5beta)-isomer|T109|T121|T123|NON|REL|NLM (2002)|000804|abbbcdef
ENTRY = Pregnanolone, (3beta, 5beta, 17alpha)-isomer|T109|T121|T123|NON|REL|NLM (2002)|000804|abbbcdef
ENTRY = Pregnanolone, (3beta, 5beta,14beta)-isomer|T109|T121|T123|NON|NRW|NLM (2002)|000804|abbbcdef
ENTRY = Pregnenolone Carbonitrile, (3 beta,16 beta)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Progesterone, (13 alpha,17 alpha)-(+-)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Progesterone, (9 beta,10 alpha)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Propoxyphene Hydrochloride, (R*,R*)-(+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Propoxyphene Hydrochloride, (R-(R*,R*))-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Propoxyphene Hydrochloride, (R-(R*,S*))-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Propoxyphene Hydrochloride, (S-(R*,R*))-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Propoxyphene Phosphate, (S-(R*,S*))-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Propoxyphene Sulfate, (S-(R*,S*))-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Receptors, Stretch, Lung|T023|NON|EQV|NLM (1994)|930119|RECEPT STRETCH LUNG|abcdefv
ENTRY = 1,2,3-Trihydroxybenzene|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|861008|abcdeef
ENTRY = Paralysis, Spinal, Quadriplegic|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = 3,3',4',5,7-Pentahydroxyflavone|T109|T123|NON|EQV|FDA SRS (2014)|NLM (2014)|130207|abbcdeef
ENTRY = Receptor, Adrenergic, alpha|T116|T192|NON|EQV|NLM (1994)|930301|abbcdef
ENTRY = Receptor, Adrenergic, beta|T116|T192|NON|EQV|NLM (1994)|930419|abbcdef
ENTRY = Receptors, Antigen, B Cell|T116|T129|T192|NON|EQV|UNK (19XX)|790524|abbbcdef
ENTRY = Receptors, Estrogen, Type I|T116|T192|NON|NRW|NLM (1993)|920513|RECEPT ESTROGEN TYPE I|abbcdefv
ENTRY = Receptors, Estrogen, Type II|T116|T192|NON|NRW|NLM (1993)|920513|RECEPT ESTROGEN TYPE II|abbcdefv
ENTRY = Receptors, Lipoprotein, LDL|T116|T192|EQV|UNK (19XX)|840525|RECEPT LIPOPROTEIN LDL|abbdefv
ENTRY = Reflex, Acoustic, Abnormal|T033|NON|NRW|NLM (2000)|991108|REFLEX ACOUSTIC ABNORM|abcdefv
ENTRY = Reflex, Anal, Absent|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Anal, Decreased|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Ankle, Abnormal|T033|NON|NRW|NLM (2000)|991108|REFLEX ANKLE ABNORM|abcdefv
ENTRY = Reflex, Ankle, Absent|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Ankle, Decreased|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Biceps, Abnormal|T033|NON|NRW|NLM (2000)|991108|REFLEX BICEPS ABNORM|abcdefv
ENTRY = Reflex, Biceps, Absent|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Biceps, Decreased|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Corneal, Absent|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Corneal, Decreased|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Deep Tendon, Abnormal|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Deep Tendon, Absent|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Gag, Absent|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Gag, Decreased|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Knee, Abnormal|T033|NON|REL|NLM (2000)|991108|REFLEX KNEE ABNORM|abcdefv
ENTRY = Reflex, Knee, Decreased|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Moro, Asymmetric|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Triceps, Abnormal|T033|NON|NRW|NLM (2000)|991108|REFLEX TRICEPS ABNORM|abcdefv
ENTRY = Reflex, Triceps, Absent|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Reflex, Triceps, Decreased|T033|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = RNA, Transfer, Suppressor|T114|T123|NRW|UNK (19XX)|880728|abbdef
ENTRY = RNA, Transfer, Amino Acid Specific|T114|T123|EQV|UNK (19XX)|870505|RNA TRANSFER AA SPECIFIC|abbdefv
ENTRY = Broad Thumbs and Great Toes, Characteristic Facies, and Mental Retardation|T019|NON|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101213|abcdeeef
ENTRY = (Sar1,Val5,Ala8)Angiotensin II|T116|T121|NON|EQV|NLM (1992)|910116|abbcdef
ENTRY = Selegiline Hydrochloride, (R,S)-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Selegiline, (R,S)-Isomer|T109|T121|REL|NLM (1999)|990913|abbdef
ENTRY = Selenomethionine, (+,-)-Isomer|T116|T121|T130|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid, Disodium Salt|T109|T121|T130|NON|NRW|NLM (2001)|000515|abbbcdef
ENTRY = Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2001)|000424|abbcdeef
ENTRY = Pachycarpine Sulfate (1:1), Pentahydrate, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|NRW|NLM (2002)|990818|abbcdef
ENTRY = Sparteine Hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|NRW|NLM (2002)|010618|abbcdef
ENTRY = Sparteine Hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|NRW|NLM (2002)|010618|abbcdef
ENTRY = Sparteine Hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|NRW|NLM (2002)|010618|abbcdef
ENTRY = Sparteine Monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|NRW|NLM (2002)|010618|abbcdef
ENTRY = Sparteine Monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|NRW|NLM (2002)|010618|abbcdef
ENTRY = Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer|T109|T121|NON|NRW|NLM (2002)|010618|abbcdef
ENTRY = Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|NRW|NLM (2002)|010618|abbcdef
ENTRY = Sparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|REL|NLM (2002)|001106|abbcdef
ENTRY = Sparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer|T109|T121|NON|NRW|NLM (2002)|010618|abbcdef
ENTRY = Sparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer|T109|T121|NON|REL|NLM (2002)|001106|abbcdef
ENTRY = Sparteine, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|T109|T121|NON|EQV|NLM (2002)|010618|abbcdef
ENTRY = Sparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer|T109|T121|NON|REL|NLM (2002)|001106|abbcdef
ENTRY = Encephaltis, Inclusion Body, Measles|T047|NON|EQV|NLM (2000)|991103|ENCEPH INCLUSION BODY MEASLES|abcdefv
ENTRY = Sulfacetamide, Monosodium Salt, Anhydrous|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Sulfisoxazole, Monosodium, Monomesylate Salt|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Support, U.S. Gov't, Non P.H.S.|T064|NON|REL|UNK (19XX)|800618|GOVT SUP NON PHS|abcdefv
ENTRY = Support, U.S. Govt, Non P.H.S.|T064|NON|REL|UNK (19XX)|810326|abcdef
ENTRY = Support, U.S. Govt, Non-P.H.S.|T064|NON|REL|UNK (19XX)|810326|abcdef
ENTRY = Support, U.S. Govt, P.H.S.|T064|REL|UNK (19XX)|810326|abdef
ENTRY = Supranuclear Palsy, Progressive, 1|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Surgical Procedure, Oral, Preprosthetic|T061|NON|EQV|NLM (1998)|961015|SURG PROCEDURE ORAL PREPROSTHETIC|abcdefv
ENTRY = Surgical Procedures, Oral, Preprosthetic|T061|NON|EQV|NLM (1998)|961015|SURG PROCEDURES ORAL PREPROSTHETIC|abcdefv
ENTRY = Procedure, Urologic Surgical, Male|T061|NON|EQV|NLM (1998)|960924|PROCEDURE UROL SURG MALE|abcdefv
ENTRY = Procedure, Urological Surgical, Male|T061|NON|EQV|NLM (1998)|960924|abcdef
ENTRY = Procedures, Urologic Surgical, Male|T061|NON|EQV|NLM (1998)|960924|PROCEDURES UROL SURG MALE|abcdefv
ENTRY = Procedures, Urological Surgical, Male|T061|NON|EQV|NLM (1998)|960924|abcdef
ENTRY = Surgical Procedure, Urologic, Male|T061|NON|EQV|NLM (1998)|960924|SURG PROCEDURE UROL MALE|abcdefv
ENTRY = Surgical Procedure, Urological, Male|T061|NON|EQV|NLM (1998)|960924|abcdef
ENTRY = Surgical Procedures, Urologic, Male|T061|NON|EQV|NLM (1998)|960924|SURG PROCEDURES UROL MALE|abcdefv
ENTRY = Surgical Procedures, Urological, Male|T061|NON|EQV|NLM (1998)|960924|abcdef
ENTRY = T-2 Toxin, alpha,4 beta-Isomer|T109|T131|REL|NLM (1999)|990913|abbdef
ENTRY = 1,2,3,4-Tetrahydro-9-acridinamine|T109|T121|NON|EQV|NLM (1995)|940324|abbcdef
ENTRY = 1,2,3,4-Tetrahydroaminoacridine|T109|T121|NON|EQV|UNK (19XX)|861114|abbcdef
ENTRY = 9-Amino-1,2,3,4-Tetrahydroacridine|T109|T121|NON|EQV|UNK (19XX)|880719|abbcdef
ENTRY = Taste Disorder, Primary, Bitter|T047|NON|NRW|NLM (2000)|991103|TASTE DIS PRIMARY BITTER|abcdefv
ENTRY = Taste Disorder, Primary, Salt|T047|NON|NRW|NLM (2000)|991103|TASTE DIS PRIMARY SALT|abcdefv
ENTRY = Taste Disorder, Primary, Sweet|T047|NON|NRW|NLM (2000)|991103|TASTE DIS PRIMARY SWEET|abcdefv
ENTRY = Taste Disorder, Secondary, Bitter|T047|NON|NRW|NLM (2000)|991103|TASTE DIS SECONDARY BITTER|abcdefv
ENTRY = Taste Disorder, Secondary, Salt|T047|NON|NRW|NLM (2000)|991103|TASTE DIS SECONDARY SALT|abcdefv
ENTRY = Taste Disorder, Secondary, Sweet|T047|NON|NRW|NLM (2000)|991103|TASTE DIS SECONDARY SWEET|abcdefv
ENTRY = Telangiectasia, Hereditary Hemorrhagic, Type 1|T047|NON|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101206|abcdeeef
ENTRY = Telangiectasia, Hereditary Hemorrhagic, of Rendu, Osler, and Weber|T047|EPO|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101206|abcdeeef
ENTRY = Arteritis, Giant Cell, Horton|T047|EPO|EQV|NLM (2000)|991108|abcdef
ENTRY = Arteritis, Giant Cell, Horton's|T047|EPO|EQV|NLM (2000)|991108|abcdef
ENTRY = Teniposide, (5a alpha,9 alpha(S*))-Isomer|T109|T121|REL|NLM (1999)|990913|abbdef
ENTRY = Tetrathionic Acid, Disodium Salt, Dihydrate|T121|T197|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 4,4,4-trifluoro-1-(2-thienyl)-1,3-butanedione|T109|T121|NON|EQV|NLM (2009)|050903|abbcdef
ENTRY = 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione|T109|T121|T123|NON|EQV|NLM (1998)|961122|abbbcdef
ENTRY = 3,5,3',5'-Tetraiodothyronine|T116|T121|T125|NON|EQV|UNK (19XX)|800731|abbbcdef
ENTRY = L-3,5,3',5'-Tetraiodothyronine|T116|T121|T125|NON|EQV|NLM (1991)|900319|abbbcdef
ENTRY = O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine|T116|T121|T125|NON|EQV|NLM (1996)|950316|abbbcdef
ENTRY = O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine|T116|T121|T125|NON|EQV|NLM (1996)|950316|abbbcdef
ENTRY = N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamin-1,1,3,3-tetroxide hydrochloride|T109|T121|NON|EQV|NLM (1977)|abbcde
ENTRY = (S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol|T109|T121|NON|EQV|NLM (1995)|940322|abbcdef
ENTRY = 17 beta-acetoxyestra-4,9,11-trien-3-one|T109|T121|NON|EQV|NLM (2012)|abbcde
ENTRY = 2,2,6,6-Tetramethyl-4-oxopiperidine-1-oxyl|T109|T121|T130|NON|EQV|NLM (1991)|900118|abbbcdef
ENTRY = 2,3,5-Tris(ethyleneimine)benzoquinone|T109|T121|NON|EQV|UNK (19XX)|821206|abbcdef
ENTRY = 1,1,1-Trichloropropene-2,3-oxide|T109|T121|NON|EQV|UNK (19XX)|861113|abbcdef
ENTRY = 1,2-Epoxy-3,3,3-Trichloropropane|T109|T121|NON|EQV|UNK (19XX)|800801|abbcdef
ENTRY = 2,4,4'-Trichloro-2'-Hydroxydiphenyl Ether|T109|T121|NON|EQV|FDA SRS (2013)|NLM (2014)|130401|abbcdeef
ENTRY = 2-Hydroxy-2',4,4'-trichlorodiphenyl Ether|T109|T121|NON|EQV|UNK (19XX)|830328|abbcdef
ENTRY = 2,4,6-Triethylimino-1,3,5-Triazine|T109|T121|NON|EQV|UNK (19XX)|840919|abbcdef
ENTRY = 2,2,2-Trifluoroethanol|T109|NON|EQV|UNK (19XX)|800815|abcdef
ENTRY = 3,3,5 Triiodothyronine|T116|T121|T125|NON|EQV|UNK (19XX)|840727|abbbcdef
ENTRY = 3,3,5-Triiodothyronine|T116|T121|T125|NON|EQV|UNK (19XX)|840727|abbbcdef
ENTRY = 1-(4-Acetoxy-2,3,5-Trimethylphenoxy)-3-Isopropylamino-2-Propanol|T109|T121|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = 10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine|T109|T121|NON|EQV|NLM (1995)|930907|abbcdef
ENTRY = 2,4,6-Trinitrobenzene Sulfonate|T109|T130|NON|NRW|UNK (19XX)|861007|abbcdef
ENTRY = 2,5,9-Trimethyl-7H-furo(3,2-g)benzopyran-7-one|T109|T121|NON|EQV|NLM (1995)|931122|abbcdef
ENTRY = 4,5',8-Trimethylpsoralen|T109|T121|NON|EQV|NLM (1993)|920218|abbcdef
ENTRY = Alcohol, Drug Abuse, and Mental Health Administration|T093|NAM|NRW|UNK (19XX)|810605|ADAMHA|abcdefv
ENTRY = Occupational Safety, Health Administration, United States|T093|NAM|EQV|NLM (1996)|950316|OCCUP SAFETY HEALTH ADMIN UNITED STATES|abcdefv
ENTRY = 5-(Bis(2-chloroethyl)amino)-2,4-(1H,3H)pyrimidinedione|T114|T121|NON|EQV|NLM (1996)|950518|abbcdef
ENTRY = 2,6,8-Trihydroxypurine|T109|T123|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = Secretoglobin, Family 1A, Member 1|T116|T123|NON|EQV|NLM (2012)|110310|abbcdef
ENTRY = Vaccines, Live, Attenuated|T121|T129|NON|EQV|NLM (2013)|120120|abbcdef
ENTRY = 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer|T109|T127|NON|NRW|NLM (2002)|000927|abbcdef
ENTRY = Sulfonium, ((3S)-3-Amino-3-Carboxypropyl)Dimethyl-, Inner Salt|T116|T121|T127|NON|EQV|NLM (2014)|130226|abbbcdef
ENTRY = Paralysis, Unilateral, Vocal Cord|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Paralysis, Vocal Cord, Unilateral|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Muscular Atrophy, Spinal, Infantile Chronic Form|T047|NON|NRW|NLM (2017)|151214|abcdef
ENTRY = Muscular Atrophy, Spinal, Intermediate Type|T047|NON|NRW|NLM (2017)|151214|abcdef
ENTRY = Muscular Atrophy, Spinal, Type I|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Muscular Atrophy, Spinal, Type II|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Muscular Atrophy, Spinal, Type III|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness|T047|NON|EQV|GHR (2014)|130418|abcdef
ENTRY = beta,epsilon-Carotene-3, 3'-Diol, (3R,3'R,6'S)-|T109|T123|NON|REL|NLM (2002)|000926|abbcdef
ENTRY = beta,epsilon-Carotene-3,3'-diol, (3S,3'R,6'S)-|T109|T123|NON|REL|NLM (2002)|000926|abbcdef
ENTRY = 3-Amino-1,1,3-propanetricarboxylic Acid|T116|T123|NON|EQV|NLM (1996)|950403|abbcdef
ENTRY = 2,4-Dichlorophenoxyacetic Acid, Ammonium Salt|T109|T131|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,4-Dichlorophenoxyacetic Acid, Lithium Salt|T109|T131|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,4-Dichlorophenoxyacetic Acid, Potassium Salt|T109|T131|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2,4-Dichlorophenoxyacetic Acid, Sodium Salt|T109|T131|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 3,4-Dihydroxyphenylacetic Acid, Monosodium Salt|T109|T123|NRW|NLM (1999)|990913|abbdef
ENTRY = 5,8,11,14 Eicosatetraynoic Acid|T109|T121|NON|EQV|NLM (1990)|891102|abbcdef
ENTRY = 5,8,11,14,17-Icosapentaenoic Acid|T109|T121|T123|NON|EQV|UNK (19XX)|850605|abbbcdef
ENTRY = 7,8-BaP-9,10-Diol Epoxide|T109|T131|EQV|UNK (19XX)|860409|abbdef
ENTRY = Benzo(a)pyrene-7,8-diol 9,10-Epoxide|T109|T131|NON|EQV|UNK (19XX)|860409|abbcdef
ENTRY = 8,11,14 Eicosatrienoic Acid|T109|NON|EQV|UNK (19XX)|780113|abcdef
ENTRY = Encephalopathy, Subcortical, Chronic Progressive|T047|NON|REL|NLM (2000)|991103|ENCEPH SUBCORTICAL CHRONIC PROGRESSIVE|abcdefv
ENTRY = Electrophoresis, Gel, 2-D|T059|EQV|NLM (1997)|960514|abdef
ENTRY = Electrophoresis, Gel, 2D|T059|EQV|NLM (1997)|960514|abdef
ENTRY = Electrophoresis, Gel, Two Dimensional|T059|NON|EQV|UNK (19XX)|880416|abcdef
ENTRY = Glucose, Blood, Self Monitoring|T060|NON|EQV|UNK (19XX)|880420|abcdef
ENTRY = Glucose, Blood, Self-Monitoring|T060|NON|EQV|UNK (19XX)|880420|abcdef
ENTRY = Antigens, Myelomonocytic, Differentiation|T116|T129|NON|EQV|NLM (1992)|901029|ANTIGENS MM DIFFER|abbcdefv
ENTRY = DNase, Site Specific, Type II|T116|T126|EQV|UNK (19XX)|880517|abbdef
ENTRY = Deoxyribonucleases, Type II, Site Specific|T116|T126|NON|EQV|UNK (19XX)|880517|abbcdef
ENTRY = Deoxyribonucleases, Type II, Site-Specific|T116|T126|NON|EQV|NLM (1989)|890208|abbcdef
ENTRY = DNase, Site Specific, Type I|T116|T126|EQV|UNK (19XX)|880517|abbdef
ENTRY = Deoxyribonucleases, Type I, Site Specific|T116|T126|NON|EQV|NLM (1989)|881205|abbcdef
ENTRY = Deoxyribonucleases, Type I, Site-Specific|T116|T126|NON|EQV|NLM (1990)|890405|abbcdef
ENTRY = DNase, Site Specific, Type III|T116|T126|EQV|UNK (19XX)|880518|abbdef
ENTRY = Deoxyribonucleases, Type III, Site Specific|T116|T126|NON|EQV|UNK (19XX)|880518|abbcdef
ENTRY = Deoxyribonucleases, Type III, Site-Specific|T116|T126|NON|EQV|NLM (1989)|890208|abbcdef
ENTRY = T Lymphotropic Virus, Type I, Simian|T005|NON|EQV|UNK (19XX)|880531|abcdef
ENTRY = Ataxia, Intermittent, with Abnormal Pyruvate Metabolism|T047|NON|EQV|OMIM (2013)|120607|abcdef
ENTRY = Ataxia, Intermittent, with Pyruvate Dehydrogenase, or Decarboxylase, Deficiency|T047|NON|EQV|OMIM (2013)|ORD (2010)|120607|abcdeef
ENTRY = Charcot-Marie-Tooth Disease, Demyelinating, Type 4f|T047|EPO|REL|OMIM (2013)|ORD (2010)|111115|abcdeef
ENTRY = Hereditary, Spastic Paraplegia, Autosomal Dominant|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Hereditary, Spastic Paraplegia, X-Linked Recessive|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Paraplegia, Spastic, Hereditary|T047|NON|EQV|UNK (19XX)|880607|abcdef
ENTRY = Spastic Paraplegia, Autosomal Dominant, Hereditary|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Spastic Paraplegia, Autosomal Recessive, Hereditary|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Spastic Paraplegia, Hereditary, Autosomal Dominant|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Spastic Paraplegia, Hereditary, Autosomal Recessive|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Spastic Paraplegia, Hereditary, X-Linked Recessive|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Spastic Paraplegia, X-Linked Recessive, Hereditary|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Leukemia, Lymphocytic, B Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, B Cell, Chronic|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Chronic Lymphocytic, B-Cell|T191|NON|EQV|NLM (2013)|111115|abcdef
ENTRY = Leukemia, Lymphoblastic, Chronic|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphocytic, Chronic, B Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Lymphocytic Leukemia, Chronic, B Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Lymphocytic Lymphoma, Diffuse, Well Differentiated|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Lymphocytic Lymphoma, Diffuse, Well-Differentiated|T191|NON|EQV|NLM (1991)|900514|LYMPHOCYTIC LYMPHOMA DIFFUSE WELL DIFFER|abcdefv
ENTRY = Lymphoma, Lymphocytic, Diffuse, Well Differentiated|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Lymphocytic, Diffuse, Well-Differentiated|T191|NON|EQV|NLM (1991)|900514|LYMPHOMA LYMPHOCYTIC DIFFUSE WELL DIFFER|abcdefv
ENTRY = Lymphoma, Lymphocytic, Well Differentiated|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Lymphocytic, Well-Differentiated|T191|NON|EQV|NLM (1991)|900514|LYMPHOMA LYMPHOCYTIC WELL DIFFER|abcdefv
ENTRY = Lymphoma, Lymphoplasmacytoid, CLL|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Small Lymphocytic, Plasmacytoid|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Leukemia, Lymphocytic, Acute, Mixed Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Mixed, B and T Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Lymphocytic Leukemia, Acute, B and T Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphocytic, T Cell|T191|EQV|UNK (19XX)|880609|abdef
ENTRY = Leukemia Lymphoma, T Cell, Acute, HTLV I Associated|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated|T191|ACX|EQV|NLM (1989)|990101|HTLV ALL|abcdefv
ENTRY = Leukemia, Lymphocytic, Chronic, T Cell|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphocytic, Chronic, T-Cell|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, T Cell, Chronic|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Lymphocytic Leukemia, T Cell, Chronic|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Lymphocytic Leukemia, T-Cell, Chronic|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myelogenous, Ph1 Positive|T191|ABX|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myelogenous, Ph1-Positive|T191|ABX|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Ph1 Positive|T191|ABX|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Ph1-Positive|T191|ABX|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Philadelphia Positive|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Philadelphia-Positive|T191|NON|EQV|NLM (1988)|990101|LEUKEMIA PHILA POS|abcdefv
ENTRY = Leukemia, Myelogenous, Aggressive Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myelogenous, Aggressive-Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Accelerated-Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Myelogenous Leukemia, Chronic, Aggressive-Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Myeloid Leukemia, Chronic, Accelerated-Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Myeloid Leukemia, Chronic, Aggressive-Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Granulocytic Leukemia, Chronic, Stable Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Granulocytic, Chronic Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myelogenous, Chronic Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Chronic Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Stable Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Myelogenous Leukemia, Chronic, Chronic Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Myeloid Leukemia, Chronic, Chronic Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloblastic, Acute|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myelocytic, Acute|T191|NON|EQV|NLM (1967)|990101|abcdef
ENTRY = Leukemia, Myeloid, Acute, M1|T191|NON|NRW|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Acute, M2|T191|NON|NRW|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Nonlymphoblastic, Acute|T191|NON|EQV|UNK (19XX)|880612|abcdef
ENTRY = Myeloid Leukemia, Acute, M1|T191|NON|NRW|UNK (19XX)|880609|abcdef
ENTRY = Myeloid Leukemia, Acute, M2|T191|NON|NRW|UNK (19XX)|880609|abcdef
ENTRY = Autism, Dementia, Ataxia, and Loss of Purposeful Hand Use|T047|NON|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101213|abcdeeef
ENTRY = 1,4,5-IP3|T109|T123|EQV|NLM (1990)|881227|1 4 5 IP3|abbdefv
ENTRY = Myoinositol 1,4,5-Triphosphate|T109|T123|NON|EQV|NLM (1990)|890404|MYOINOSITOL 1 4 5 TRIPHOSPHATE|abbcdefv
ENTRY = Lung Malformation, Cystic Adenomatoid, Congenital|T019|NON|EQV|NLM (1990)|890124|LUNG MALFORMATION CYSTIC ADENOMATOID CONGEN|abcdefv
ENTRY = N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|T109|T131|NON|EQV|NLM (1990)|890214|abbcdef
ENTRY = 1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-|T109|T121|NON|EQV|NLM (2005)|031125|abbcdef
ENTRY = 24,25-Dihydroxyvitamin D 3, (3beta,5Z,7E,24R)-Isomer|T109|T127|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol|T109|T127|NON|EQV|NLM (1990)|890201|abbcdef
ENTRY = 17 beta-Hydroxy-17 alpha-methylestra-4,9,11-trien-3-one|T109|T121|NON|EQV|NLM (1990)|890227|17 BETA HYDROXY 17 ALPHA METHYLESTRA 4 9 11 TRIEN 3 ONE|abbcdefv
ENTRY = Enalaprilat, (R)-Isomer, Anhydrous|T109|T116|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Tomography, X-Ray Computed, Scanner|T074|NON|EQV|NLM (1990)|890419|TOMOGR X RAY COMPUTED SCANNER|abcdefv
ENTRY = Drainage, Respiratory, Postural|T061|NON|EQV|IOM (1990)|890414|abcdef
ENTRY = Regulation, Gene Expression, Bacterial|T045|NON|EQV|NLM (1992)|901015|abcdef
ENTRY = Regulation, Gene Expression, Fungal|T045|NON|EQV|NLM (1992)|901015|abcdef
ENTRY = Regulation, Gene Expression, Viral|T045|NON|EQV|NLM (1992)|901015|abcdef
ENTRY = National Academies of Science, Engineering, and Medicine (US) Health and Medicine Division|T093|ABX|EQV|NLM (2017)|160701|abcdef
ENTRY = Regulation, Gene Expression, Enzymologic|T045|NON|EQV|NLM (1992)|901015|abcdef
ENTRY = Regulation, Gene Expression, Neoplastic|T045|NON|EQV|NLM (1992)|901015|abcdef
ENTRY = Regulation, Gene Expression, Leukemic|T045|NON|EQV|NLM (1992)|901015|abcdef
ENTRY = Evoked Potential, Auditory, Brainstem|T042|T060|NON|EQV|NLM (1991)|890804|abbcdef
ENTRY = Evoked Potentials, Auditory, Brainstem|T042|T060|NON|EQV|NLM (1991)|890803|abbcdef
ENTRY = Evoked Response, Auditory, Brain Stem|T042|T060|NON|EQV|NLM (1991)|890804|abbcdef
ENTRY = Evoked Response, Auditory, Brainstem|T042|T060|NON|EQV|NLM (1991)|890804|abbcdef
ENTRY = Evoked Responses, Auditory, Brainstem|T042|T060|NON|EQV|NLM (1991)|890804|abbcdef
ENTRY = Encephalopathy, Subacute Spongiform, Gerstmann-Straussler Type|T047|EPO|EQV|NLM (2010)|OMIM (2013)|ORD (2010)|090514|abcdeeef
ENTRY = Procedure, Endoscopic Gastrointestinal, Surgical|T060|T061|NON|NRW|NLM (2000)|991103|PROCEDURE ENDOSCOPIC GASTROINTESTINAL SURG|abbcdefv
ENTRY = Procedures, Endoscopic Gastrointestinal, Surgical|T060|T061|NON|NRW|NLM (2000)|991103|PROCEDURES ENDOSCOPIC GASTROINTESTINAL SURG|abbcdefv
ENTRY = Epidermolysis Bullosa, Junctional, Herlitz Type|T047|EPO|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101213|abcdeeef
ENTRY = Epidermolysis Bullosa, Junctional, Herlitz-Pearson Type|T047|EPO|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101213|abcdeeef
ENTRY = Ichthyosis, Spastic Neurologic Disorder, and Oligophrenia|T019|T047|NON|EQV|NLM (2010)|OMIM (2013)|ORD (2010)|090609|abbcdeeef
ENTRY = Endoscopic, Digestive System, Surgery|T060|T061|NON|NRW|NLM (2000)|991103|ENDOSCOPIC DIGESTIVE SYSTEM SURG|abbcdefv
ENTRY = Endoscopic, Digestive System, Surgical Procedure|T060|T061|NON|NRW|NLM (2000)|991103|ENDOSCOPIC DIGESTIVE SYSTEM SURG PROCEDURE|abbcdefv
ENTRY = Procedure, Digestive System, Endoscopic, Surgical|T060|T061|NON|NRW|NLM (2000)|991103|PROCEDURE DIGESTIVE SYSTEM ENDOSCOPIC SURG|abbcdefv
ENTRY = Procedure, Endoscopic, Digestive System, Surgical|T060|T061|NON|NRW|NLM (2000)|991103|PROCEDURE ENDOSCOPIC DIGESTIVE SYSTEM SURGICAL|abbcdefv
ENTRY = Procedures, Digestive System, Endoscopic, Surgical|T060|T061|NON|NRW|NLM (2000)|991103|PROCEDURES DIGESTIVE SYSTEM ENDOSCOPIC SURG|abbcdefv
ENTRY = Procedures, Endoscopic, Digestive System, Surgical|T060|T061|NON|NRW|NLM (2000)|991103|PROCEDURES ENDOSCOPIC DIGESTIVE SYSTEM SURG|abbcdefv
ENTRY = Surgery, Endoscopic, Digestive System|T060|T061|NON|NRW|NLM (2000)|991103|SURG ENDOSCOPIC DIGESTIVE SYSTEM|abbcdefv
ENTRY = Surgical Procedure, Endoscopic, Digestive System|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURE ENDOSCOPIC DIGESTIVE SYSTEM|abbcdefv
ENTRY = 2-(Acetyloxy)-N,N,N-trimethyl-1-propanaminium Chloride|T109|T121|T130|NON|EQV|NLM (1995)|940404|abbbcdef
ENTRY = 2,5-Cyclohexadiene-1,4-Diones|T109|NON|NRW|NLM (2007)|060418|abcdef
ENTRY = Lymphoma, Immunoblastic, Large Cell|T191|NON|EQV|NLM (1991)|900524|abcdef
ENTRY = Lymphoma, Large Cell, Immunoblastic|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Large Cell, Diffuse|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Lymphoma, Large Lymphoid, Diffuse|T191|NON|EQV|NLM (1991)|900513|abcdef
ENTRY = Lymphoma, Large-Cell, Diffuse|T191|NON|EQV|NLM (1991)|990101|LYMPHOMA LARGE DIFFUSE|abcdefv
ENTRY = Lymphoma, T Cell, Cutaneous|T191|EQV|NLM (1991)|900514|abdef
ENTRY = Lymphoma, T Cell, Peripheral|T191|NON|EQV|NLM (1991)|900514|abcdef
ENTRY = Neurofibromatosis, Central, NF 2|T191|NON|EQV|NLM (1992)|900905|abcdef
ENTRY = Electrophoresis, Gel, Pulsed Field|T059|NON|EQV|NLM (1992)|900906|abcdef
ENTRY = Gangliosidosis, Generalized GM1, Adult Type|T047|ABX|NRW|OMIM (2013)|120622|abcdef
ENTRY = Gangliosidosis, Generalized GM1, Chronic Type|T047|ABX|NRW|OMIM (2013)|120622|abcdef
ENTRY = Gangliosidosis, Generalized GM1, Infantile Form|T047|ABX|NRW|OMIM (2013)|120622|abcdef
ENTRY = Gangliosidosis, Generalized GM1, Juvenile Type|T047|NON|NRW|NLM (2011)|OMIM (2013)|100401|abcdeef
ENTRY = Gangliosidosis, Generalized GM1, Type 1|T047|NON|NRW|NLM (2007)|OMIM (2013)|050727|abcdeef
ENTRY = Gangliosidosis, Generalized GM1, Type 2|T047|NON|NRW|NLM (2007)|OMIM (2013)|050727|abcdeef
ENTRY = Gangliosidosis, Generalized GM1, Type 3|T047|NON|NRW|NLM (2007)|OMIM (2013)|050727|abcdeef
ENTRY = Gangliosidosis, Generalized GM1, Type I|T047|ABX|NRW|OMIM (2013)|120622|abcdef
ENTRY = Gangliosidosis, Generalized GM1, Type II|T047|NON|NRW|OMIM (2013)|120621|abcdef
ENTRY = Gangliosidosis, Generalized GM1, Type III|T047|NON|NRW|OMIM (2013)|120621|abcdef
ENTRY = Aphidicolin, (3-S-(3alpha,4beta,4abeta,6aalpha,8alpha,9alpha,11aalpha,11balpha))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Misoprostol, (11alpha,13E)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Misoprostol, (11alpha,13E,16R)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Misoprostol, (11alpha,13Z)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Misoprostol, (11alpha.13E,16S)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Misoprostol, (11beta,13E)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Misoprostol, (11beta,13E,16R)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Misoprostol, (11beta,13E,16S)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Aflatoxin B1, (6aR-cis)-Isomer, 14C-Labeled|T109|T131|T196|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Aflatoxin B1, (6aR-cis)-Isomer, 2H-Labeled|T109|T131|T196|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Aflatoxin B1, (6aR-cis)-Isomer, 3H-Labeled|T109|T131|T196|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Aflatoxin B1, cis(+,-)-Isomer|T109|T131|T196|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Enprostil, (1R-(1(R*),2beta(1E,3R*),3alpha))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Enprostil, (1R-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Enprostil, (1R-(1alpha,2beta(1E,3R*),3alpha))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Enprostil, (1S-(1alpha(R*),2beta(1E,3R*),3alpha))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Enprostil, (1S-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Enprostil, (1alpha(R*),2beta(1E,3R*),3alpha)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Enprostil, (1alpha(R*),2beta(1E,3S*),3alpha)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Enprostil, (1alpha,2alpha(1E,3S*),3beta)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Enprostil, (1alpha,2beta(1E,3R*),3alpha)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Receptors, Antigen, T Cell, gamma delta|T116|T129|T192|EQV|NLM (1992)|901115|RECEPT ANTIGEN T CELL G D|abbbdefv
ENTRY = Receptors, Antigen, T Cell, alpha beta|T116|T129|T192|EQV|NLM (1992)|901115|RECEPT ANTIGEN T CELL A B|abbbdefv
ENTRY = Mupirocin, Calcium Salt (2:1), Dihydrate|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = (all-Z)-5,8,11,14-Eicosatetraenoic acid|T109|NON|EQV|NLM (1998)|961119|abcdef
ENTRY = Arachidonic Acid, (all-Z)-Isomer, 1-(14)C-Labeled|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Arachidonic Acid, (all-Z)-isomer, 3H-Labeled|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Arachidonic Acid, Ammonium Salt, (all-Z)-Isomer|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Arachidonic Acid, Cerium Salt, (all-Z)-Isomer|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Arachidonic Acid, Cesium Salt, (all-Z)-Isomer|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Arachidonic Acid, Lithium Salt, (all-Z)-Isomer|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Arachidonic Acid, Potassium Salt, (all-Z)-Isomer|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Arachidonic Acid, Sodium Salt, (all-Z)-Isomer|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Arachidonic Acid, Zinc Salt, (all-Z)-Isomer|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Pseudotumor, Inflammatory, Pulmonary|T047|NON|EQV|NLM (1992)|901231|PSEUDOTUMOR INFLAMM PULM|abcdefv
ENTRY = Granuloma, Plasma Cell, Orbital|T047|NON|NRW|NLM (1992)|990101|abcdef
ENTRY = Pseudotumor, Inflammatory, Orbital|T047|NON|EQV|NLM (1992)|901231|PSEUDOTUMOR INFLAMM ORBITAL|abcdefv
ENTRY = Immunoglobulins, Intravenous, Human|T116|T121|T129|NON|NRW|NLM (2013)|111201|abbbcdef
ENTRY = Peritonitis, Infectious, Feline|T047|NON|EQV|NLM (1992)|910130|PERITONITIS INFECT FELINE|abcdefv
ENTRY = Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome|T047|NON|EQV|NLM (2011)|ORD (2010)|100324|abcdeef
ENTRY = Diabetes Mellitus, Addison Disease, Myxedema|T047|EPO|NRW|OMIM (2013)|111115|abcdef
ENTRY = Diabetes Mellitus, Addison's Disease, Myxedema|T047|EPO|NRW|NLM (2012)|ORD (2010)|101130|abcdeef
ENTRY = Polycystic Kidney Disease, Adult, Type II|T047|NON|NRW|OMIM (2013)|121212|abcdef
ENTRY = Plaque, Ulcerating, Carotid Artery|T020|NON|REL|NLM (2000)|991103|abcdef
ENTRY = Gram Negative Anaerobic Straight, Curved, and Helical Rods|T007|EPO|EQV|NLM (1992)|910403|abcdef
ENTRY = Swainsonine, (1R-(2 beta,8a alpha))-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Swainsonine, (2 beta,8a alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Swainsonine, (8 alpha,8a alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Epilepsy, Cryptogenic, Partial Complex|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Epilepsy, Symptomatic, Partial Complex|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Epilepsy, Benign Frontal, Childhood|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Polycystic Kidney Disease, Infantile, Type 1|T019|T047|NON|EQV|NLM (2012)|ORD (2010)|101214|abbcdeef
ENTRY = Encephalopathies, Spongiform, Transmissible|T047|NON|EQV|NLM (2000)|991108|ENCEPH SPONGIFORM TRANSM|abcdefv
ENTRY = Nonoxynol, 1(4)-Sulfate, Sodium Salt|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Nonoxynol, 4-Sulfate, Ammonium Salt|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes|T047|NON|EQV|GHR (2014)|130418|abcdef
ENTRY = Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes|T047|NON|EQV|GHR (2014)|OMIM (2013)|111115|abcdeef
ENTRY = Acitretin, (Z,E,E,E)-Isomer|T109|T121|REL|NLM (1999)|990913|abbdef
ENTRY = Medroxyprogesterone 17-Acetate, (6 alpha,17 alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Procaterol Monohydrochloride, (R*,R*)-(+)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Procaterol Monohydrochloride, (R*,R*)-(+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Procaterol Monohydrochloride, (R*,R*)-(-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Procaterol Monohydrochloride, (R*,S*)-(+)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Procaterol Monohydrochloride, (R*,S*)-(-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Procaterol, (R*,R*)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Procaterol, (R*,S*)-(-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Celiprolol, (+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Celiprolol, Monohydrochloride, (R)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Celiprolol, Monohydrochloride, (S)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = N'-(3-Acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethylurea|T109|T121|NON|EQV|NLM (1995)|940321|abbcdef
ENTRY = Menogaril, (5 alpha,11 beta)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine|T109|T121|NON|NRW|NLM (1995)|940321|abbcdef
ENTRY = Ondansetron, (+,-)-Isomer|T109|T121|EQV|NLM (1999)|990913|abbdef
ENTRY = Adenosine Triphosphatase, Calcium, Magnesium|T116|T126|NON|EQV|NLM (1993)|920410|abbcdef
ENTRY = Etodolac, Monosodium Salt, (+-) Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Etodolac, Monosodium Salt, (S)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Amlodipine, (+-)-Isomer, Maleate (1:1)|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Amlodipine, (S)-Isomer, Maleate (1:1)|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Fosinopril, (1(S*(R*)),2 alpha,4 alpha)-(D-Pro)-Isomer|T109|T116|T121|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = Fosinopril, (1(S*(R*)),2 alpha,4 beta)-Isomer|T109|T116|T121|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Fosinopril, (1(S*(S*)),2 alpha,4 beta)-Isomer|T109|T116|T121|NON|REL|NLM (1999)|990913|abbbcdef
ENTRY = 4-(8-Chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester|T109|T121|NON|EQV|NLM (1995)|930831|abbcdef
ENTRY = Hemolysis, Elevated Liver Enzymes, Lowered Platelets|T047|NON|EQV|NLM (2011)|ORD (2010)|080925|abcdeef
ENTRY = 8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (R)-Isomer,|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (S)-Isomer,|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 8-Hydroxy-2-(di-n-propylamino)tetralin Hydrochloride, (R)-Isomer,|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cyproterone Acetate, (1 alpha,2 alpha)-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Ribonucleoproteins, Small, U1|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef
ENTRY = Ribonucleoproteins, Small, U2|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef
ENTRY = Ribonucleoproteins, Small, U4-U6|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef
ENTRY = Ribonucleoproteins, Small, U5|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef
ENTRY = Hypogonadotropic Hypogonadism, Anosmia, and Midline Cranial Anomalies (Cleft Lip, Cleft Palate and Imperfect Fusion)|T047|NON|NRW|ORD (2010)|120620|abcdef
ENTRY = Kallmann Syndrome, Type 1, X-linked|T047|NON|NRW|NLM (2010)|ORD (2010)|090513|abcdeef
ENTRY = Kallmann Syndrome, Type 3, Recessive|T047|EPO|NRW|ORD (2010)|120620|abcdef
ENTRY = 2-Propenoic acid, 2-methyl-, (1-methylethylidene)bis(4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)) ester, homopolymer|T109|T122|NON|NRW|NLM (2001)|000509|abbcdef
ENTRY = 1,5-Dideoxy-1,5-imino-D-mannitol|T109|T121|REL|NLM (1999)|990913|abbdef
ENTRY = Ichthyosis, Lamellar, 1|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Porokeratosis Plantaris, Palmaris, Et Disseminata|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Porokeratosis, Disseminated Superficial Actinic, 2|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Porokeratosis, Palmar, Plantar, And Disseminated 1|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Adenosine Triphosphatase, Hydrogen, Potassium|T116|T126|NON|EQV|NLM (1993)|920410|abbcdef
ENTRY = Hydrogen, Potassium, Adenosine Triphosphatase|T116|T126|NON|EQV|NLM (1993)|920414|abbcdef
ENTRY = Healthcare Quality, Access, and Evaluation|T078|NON|EQV|NLM (1998)|970110|abcdef
ENTRY = Wilms Tumor, Aniridia, Genitourinary Anomalies, And Mental Retardation Syndrome|T019|T191|NON|EQV|GHR (2014)|OMIM (2013)|111115|abbcdeef
ENTRY = Asbestos, Serpentine, Chrysotile (Mg3(OH)4(Si2O5))|T131|T197|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcinosis, Raynaud's phenomenon, Esophageal dismobility, Sclerodactyly, Telangiectasia Syndrome|T047|EPO|EQV|NLM (2010)|090515|abcdef
ENTRY = Leukoplakia, Hairy, Oral|T191|NON|EQV|NLM (1994)|920831|abcdef
ENTRY = Purchasing, Hospital, Group|T058|NON|NRW|NLM (1994)|921228|PURCHASING HOSP GROUP|abcdefv
ENTRY = Purchasing, Hospital, Joint|T058|NON|NRW|NLM (1994)|921228|PURCHASING HOSP JOINT|abcdefv
ENTRY = Purchasing, Hospital, Shared|T058|NON|NRW|NLM (1994)|921228|PURCHASING HOSP SHARED|abcdefv
ENTRY = 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|T109|T121|NON|EQV|NLM (1995)|940217|abbcdef
ENTRY = Nedocromil, Disodium salt, Hydrate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 4,4'-Diisothiocyano-2,2'-Stilbene Disulfonic Acid|T109|T121|NON|EQV|NLM (1994)|921021|abbcdef
ENTRY = alpha-Linolenic Acid, (E,E,E)-Isomer|T109|T123|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = alpha-Linolenic Acid, (E,E,Z)-Isomer|T109|T123|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = alpha-Linolenic Acid, (E,Z,E)-Isomer|T109|T123|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = alpha-Linolenic Acid, (E,Z,Z)-Isomer|T109|T123|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = alpha-Linolenic Acid, (Z,E,E)-Isomer|T109|T123|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = alpha-Linolenic Acid, (Z,E,Z)-Isomer|T109|T123|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = alpha-Linolenic Acid, (Z,Z,E)-Isomer|T109|T123|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Hair Cell, Auditory, Outer|T025|NON|EQV|NLM (2012)|110317|abcdef
ENTRY = Hair Cells, Auditory, Outer Inner|T025|NON|EQV|NLM (2016)|141118|abcdef
ENTRY = 2',3'-Didehydro-2',3'-dideoxythmidine|T114|T121|NON|EQV|NLM (1994)|930216|abbcdef
ENTRY = Receptors, 1,25-Dihydroxyvitamin D 3|T116|T192|NON|EQV|NLM (1994)|930415|RECEPT DIHYDROXYVITAMIN D 3|abbcdefv
ENTRY = Carcinoma, Invasive Ductal, Breast|T191|NON|EQV|NLM (2004)|030206|abcdef
ENTRY = Ductal, Lobular, and Medullary Neoplasms|T191|NON|EQV|NLM (1998)|960905|DUCTAL LOBULAR MEDULLARY NEOPL|abcdefv
ENTRY = Receptors, 2,3,7,8-Tetrachlorodibenzo-p-dioxin|T116|T192|NON|EQV|NLM (1994)|930415|RECEPT TETRACHLORODIBENZODIOXIN|abbcdefv
ENTRY = Receptor, Adrenergic, alpha-1|T116|T192|NON|EQV|NLM (1994)|930416|abbcdef
ENTRY = Receptor, Adrenergic, alpha-1A|T116|T192|NON|NRW|NLM (2011)|100312|abbcdef
ENTRY = Receptor, Adrenergic, alpha-1B|T116|T192|NON|NRW|NLM (2011)|100312|abbcdef
ENTRY = Receptor, Adrenergic, alpha-1D|T116|T192|NON|NRW|NLM (2011)|100312|abbcdef
ENTRY = Receptors, Adrenergic, alpha-1A|T116|T192|NON|NRW|NLM (2011)|100312|abbcdef
ENTRY = Receptors, Adrenergic, alpha-1B|T116|T192|NON|NRW|NLM (2011)|100312|abbcdef
ENTRY = Receptors, Adrenergic, alpha-1D|T116|T192|NON|NRW|NLM (2011)|100312|abbcdef
ENTRY = Receptor, Adrenergic, alpha-2|T116|T192|NON|EQV|NLM (1994)|930416|abbcdef
ENTRY = Receptor, Adrenergic, alpha-2A|T116|T192|NON|NRW|NLM (2011)|100315|abbcdef
ENTRY = Receptor, Adrenergic, alpha-2B|T116|T192|NON|NRW|NLM (2011)|100315|abbcdef
ENTRY = Receptor, Adrenergic, alpha-2C|T116|T192|NON|NRW|NLM (2011)|100315|abbcdef
ENTRY = Receptor, Adrenergic, alpha-2D|T116|T192|NON|NRW|NLM (2011)|100315|abbcdef
ENTRY = Receptors, Adrenergic, alpha-2A|T116|T192|NON|NRW|NLM (2011)|100315|abbcdef
ENTRY = Receptors, Adrenergic, alpha-2B|T116|T192|NON|NRW|NLM (2011)|100315|abbcdef
ENTRY = Receptors, Adrenergic, alpha-2D|T116|T192|NON|NRW|NLM (2011)|100315|abbcdef
ENTRY = Receptor, Adrenergic, beta-1|T116|T192|NON|EQV|NLM (1994)|930416|abbcdef
ENTRY = Receptor, Adrenergic, beta-2|T116|T192|NON|EQV|NLM (1994)|930416|abbcdef
ENTRY = AMPA, (R)-Isomer, Monohydrobromide|T109|ABX|NRW|NLM (1999)|990913|abcdef
ENTRY = AMPA, (S)-Isomer, Monohydrobromide|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Diabetes Insipidus, Nephrogenic, Autosomal|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Diabetes Insipidus, Nephrogenic, Type 1|T047|NON|NRW|NLM (2012)|ORD (2010)|101201|abcdeef
ENTRY = Diabetes Insipidus, Nephrogenic, Type I|T047|NON|NRW|NLM (2006)|OMIM (2013)|040823|abcdeef
ENTRY = Diabetes Insipidus, Nephrogenic, Type II|T047|NON|NRW|NLM (2006)|OMIM (2013)|040823|abcdeef
ENTRY = Diabetes Insipidus, Nephrogenic, X-Linked|T047|NON|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101201|abcdeeef
ENTRY = Regulation, Gene Expression, Plant|T045|NON|EQV|NLM (1995)|931126|abcdef
ENTRY = Regulation, Gene Expression, Developmental|T045|NON|EQV|NLM (1995)|931126|abcdef
ENTRY = Regulation, Gene Expression, Embryologic|T045|NON|EQV|NLM (1995)|931126|abcdef
ENTRY = Tumors, Breast, Male|T191|NON|EQV|NLM (2005)|040622|abcdef
ENTRY = 1,4-dihydro-2,3-dihydroxy-7-nitro-6-quinoxalinecarbonitrile|T109|T121|EQV|NLM (1999)|990913|abbdef
ENTRY = Neuromata, Mucosal, With Endocrine Tumors|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Aphasia, Acquired, With Convulsive Disorder|T048|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Aphasia, Epileptic, Acquired|T048|NON|EQV|NLM (1996)|940719|abcdef
ENTRY = Adrenoleukodystrophy, Autosomal, Neonatal Form|T047|NON|NRW|NLM (2010)|ORD (2010)|090601|abcdeef
ENTRY = Myositis, Inclusion Body, Sporadic|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Chorionic Gonadotropin, beta Chain, Human|T116|T125|NON|EQV|NLM (2003)|010910|abbcdef
ENTRY = Chorionic Gonadotropin, beta Polypeptide, Human|T116|T125|NON|EQV|NLM (2003)|010910|abbcdef
ENTRY = Polydactyly, Sex Reversal, Renal Hypoplasia, And Unilobar Lung|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Phosphatidylinositol Phosphate, PtdIns(4,5)P2|T109|T123|NON|EQV|NLM (2011)|100407|abbcdef
ENTRY = Branchial Clefts with Characteristic Facies, Growth Retardation, Imperforate Nasolacrimal Duct, and Premature Aging|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = Nuclear Antigens, Herpesvirus 4, Human|T116|T129|NON|EQV|NLM (2006)|050427|abbcdef
ENTRY = 17-Hydroxyprogesterone, (9 beta, 10 alpha)-Isomer|T109|T121|T125|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = NG-Nitroarginine Methyl Ester, L-Orn-Isomer, Monohydrochloride|T116|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Propanoic Acid, 2-Hydroxy-, (2R)-|T109|NON|NRW|FDA SRS (2014)|NLM (2014)|130612|abcdeef
ENTRY = Propanoic Acid, 2-Hydroxy-, (2S)-|T109|T123|NON|NRW|FDA SRS (2014)|NLM (2014)|130612|abbcdeef
ENTRY = Syncope, Vasovagal, Neurally-Mediated|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Neoplasm, Benign, Optic Nerve|T191|NON|NRW|NLM (2000)|991104|NEOPL BENIGN OPTIC NERVE|abcdefv
ENTRY = Neoplasm, Optic Nerve, Benign|T191|NON|NRW|NLM (2000)|991104|NEOPL OPTIC NERVE BENIGN|abcdefv
ENTRY = Tumor, Benign, Optic Nerve|T191|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Tumor, Malignant, Optic Nerve|T191|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Tumor, Optic Nerve, Benign|T191|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Tumor, Optic Nerve, Malignant|T191|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Blindness, Cortical, Post-Ictal|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Blindness, Cortical, Transient|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Arthroplasties, Replacement, Hip|T061|NON|EQV|NLM (1998)|961010|ARTHROPLASTIES REPLACE HIP|abcdefv
ENTRY = Arthroplasties, Replacement, Knee|T061|NON|EQV|NLM (1998)|961010|ARTHROPLASTIES REPLACE KNEE|abcdefv
ENTRY = Arthroplasty, Replacement, Partial Knee|T061|NON|NRW|NLM (2015)|130930|abcdef
ENTRY = Inhibitor, Coagulation Factor, Blood|T123|NON|EQV|NLM (1998)|961216|abcdef
ENTRY = Inhibitors, Coagulation Factor, Blood|T123|NON|EQV|NLM (1998)|961216|INHIB COAG FACTORS BLOOD|abcdefv
ENTRY = Linoelaidic Acid, (E,Z)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, (E,E)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, (Z,E)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, (Z,Z)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, (Z,Z)-Isomer, 14C-Labeled|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, Ammonium Salt, (Z,Z)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, Calcium Salt, (Z,Z)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, Potassium Salt, (Z,Z)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, Sodium Salt, (E,E)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Linoleic Acid, Sodium Salt, (Z,Z)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = cis,cis-9,12-Octadecadienoic Acid|T109|T123|NON|NRW|NLM (2001)|000530|abbcdef
ENTRY = trans,trans-9,12-Octadecadienoic Acid|T109|T123|NON|NRW|NLM (1998)|970205|abbcdef
ENTRY = 2,3-Diphosphoglycerate, (D)-Isomer|T109|T123|REL|NLM (1999)|990913|abbdef
ENTRY = (15S)-Hydroxy-11 alpha, 9 alpha-(epoxymethano)prosta-5Z, 13E-dienoic Acid|T109|T121|NON|EQV|NLM (1998)|970204|abbcdef
ENTRY = (15S)hydroxy-9alpha,11alpha-(epoxymethano)prosta-5,13-dienoic acid|T109|T121|NON|EQV|NLM (2004)|abbcde
ENTRY = 9,11-Dideoxy-11 alpha,9 alpha-epoxymethanoprostaglandin F2 alpha|T109|T121|NON|EQV|NLM (1998)|970204|abbcdef
ENTRY = 9,11-Dideoxy-11 alpha,9-alpha-epoxymethano-PGF2 alpha|T109|T121|EQV|NLM (1998)|970204|abbdef
ENTRY = Neopterin, (R*, R*)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = alpha-Methyltyrosine, (+,-)-Isomer|T116|T121|NON|NRW|NLM (2002)|001130|abbcdef
ENTRY = alpha-Methyltyrosine, (D,L)-Isomer|T116|T121|NON|NRW|NLM (2002)|001130|abbcdef
ENTRY = Regulation, Gene Expression, Archaeal|T045|NON|EQV|NLM (1998)|970117|abcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+)-Isomer|T109|T121|NON|NRW|NLM (2002)|001019|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monohydrochloride, (trans)-(+-)-Isomer,|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+-)-Isomer|T109|T121|NON|NRW|NLM (2002)|001019|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1R-cis)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1S-cis)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Polymethyl Methacrylate, Surgical Simplex Bone Cement, Ammonium Salt|T109|T122|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Synovitis, Acne, Pustlosis, Hyperostosis, and Osteomyelitis|T047|NON|EQV|NLM (2010)|ORD (2010)|090415|abcdeef
ENTRY = Hyperglycinemia, Nonketotic, Type I|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Hyperglycinemia, Nonketotic, Type II|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Hyperglycinemia, Nonketotic, Type III|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Deficiency, Argininosuccinic Acid Synthetase, Complete|T047|NON|NRW|NLM (2000)|991012|DEFIC ARGININOSUCCINIC ACID SYNTHETASE COMPLETE|abcdefv
ENTRY = Deficiency, Argininosuccinic Acid Synthetase, Partial|T047|NON|NRW|NLM (2000)|991012|DEFIC ARGININOSUCCINIC ACID SYNTHETASE PARTIAL|abcdefv
ENTRY = ATP-Binding Cassette, Sub-Family B, Member 1|T109|T116|T123|T129|NON|EQV|NLM (2002)|010413|abbbbcdef
ENTRY = Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type|T047|EPO|NRW|NLM (2013)|120618|abcdef
ENTRY = Syndrome, Sleep Apnea, Obstructive|T047|NON|EQV|NLM (2000)|991012|abcdef
ENTRY = Syndrome, Upper Airway Resistance, Sleep Apnea|T047|NON|REL|NLM (2000)|991012|abcdef
ENTRY = Sleep Apnea, Newborn, Primary|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Periodic Leg Movements, Excessive, Sleep-Related|T047|NON|EQV|NLM (2000)|991012|PERIODIC LEG MOVEMENTS EXCESSIVE SLEEP RELAT|abcdefv
ENTRY = Myoclonic Epilepsy, Juvenile, 1|T047|NON|EQV|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Petit Mal, Impulsive, Janz|T047|EPO|EQV|NLM (2000)|991012|abcdef
ENTRY = Ataxia, Chorea, Seizures, And Dementia|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Head Injuries, Penetrating, Missile|T037|NON|NRW|NLM (2000)|991012|HEAD INJ PENETRATING MISSILE|abcdefv
ENTRY = Skull Fracture, Basilar, Childhood|T037|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Coma, Post-Traumatic, Prolonged|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Injury, Vascular, Brain|T037|NON|EQV|NLM (2000)|991012|INJ VASCULAR BRAIN|abcdefv
ENTRY = Phlebitis, Sagittal Sinus, Septic|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Cavernous Sinus, Phlebitis, Septic|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Phlebitis, Cavernous Sinus, Septic|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Phlebitis, Lateral Sinus, Septic|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Poisoning, Arsenic, Nervous System|T037|NON|EQV|NLM (2000)|991012|POIS ARSENIC NERVOUS SYSTEM|abcdefv
ENTRY = Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|T037|NON|EQV|NLM (2000)|991012|POIS 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE|abcdefv
ENTRY = Polyneuropathy, Inflammatory Demyelinating, Acute|T033|T047|NON|EQV|OMIM (2013)|111115|abbcdef
ENTRY = Polyneuropathy, Inflammatory Demyelinating, Chronic|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Autoimmune Diseases, Demyelinating, Brain|T047|NON|NRW|NLM (2000)|991012|AUTOIMMUNE DIS DEMYELINATING BRAIN|abcdefv
ENTRY = Demyelinating Disease, Autoimmune, CNS|T047|NON|EQV|NLM (2000)|991012|DEMYELINATING DIS AUTOIMMUNE CNS|abcdefv
ENTRY = Vasculitis, CNS, Secondary|T047|NON|NRW|NLM (2000)|991012|VASCULITIS CNS SECOND|abcdefv
ENTRY = Myasthenic Syndrome, Congenital, Slow-Channel|T047|NON|NRW|NLM (2000)|OMIM (2013)|ORD (2010)|090528|abcdeeef
ENTRY = Neoplasms, Brainstem, Primary|T191|NON|NRW|NLM (2000)|991012|NEOPL BRAINSTEM PRIMARY|abcdefv
ENTRY = Infections, Fungal, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|INFECT FUNGAL CNS|abcdefv
ENTRY = Glioma, Optic Nerve, Adult|T191|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Glioma, Optic Nerve, Childhood|T191|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Leukodystrophy, Hypomyelinating, 1|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Myokymia, Myotonia, Muscle Wasting, And Hyperhidrosis|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Cardiomyopathy, Dilated, 3B|T047|NON|EQV|OMIM (2013)|130614|abcdef
ENTRY = Cardiomyopathy, Dilated, X-Linked|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Muscular Dystrophy, Childhood, Pseudohypertrophic|T047|NON|EQV|NLM (2000)|991012|abcdef
ENTRY = Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type|T047|EPO|REL|OMIM (2013)|111115|abcdef
ENTRY = Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type|T047|EPO|EQV|NLM (2011)|OMIM (2013)|ORD (2010)|100421|abcdeeef
ENTRY = Muscular Dystrophy, Pseudohypertrophic, Childhood|T047|NON|EQV|NLM (2000)|991012|abcdef
ENTRY = Muscular Dystrophy, Emery-Dreifuss, Autosomal Dominant|T047|EPO|NRW|NLM (2005)|040409|abcdef
ENTRY = Muscular Dystrophy, Emery-Dreifuss, Autosomal Recessive|T047|EPO|NRW|NLM (2005)|040409|abcdef
ENTRY = Infarction, Anterior Circulation, Brain|T047|NON|NRW|NLM (2000)|991012|INFARCT ANTERIOR CIRC BRAIN|abcdefv
ENTRY = Infarction, Brain, Anterior Circulation|T047|NON|NRW|NLM (2000)|991012|INFARCT BRAIN ANTERIOR CIRC|abcdefv
ENTRY = Infarction, Brain, Posterior Circulation|T047|NON|NRW|NLM (2000)|991012|INFARCT BRAIN POSTERIOR CIRC|abcdefv
ENTRY = Infarction, Posterior Circulation, Brain|T047|NON|NRW|NLM (2000)|991012|INFARCT POSTERIOR CIRC BRAIN|abcdefv
ENTRY = Lymphocytic Lymphoma, Diffuse, Poorly Differentiated|T047|NON|EQV|NLM (1991)|900514|LYMPHOCYTIC LYMPHOMA DIFFUSE POORLY DIFFER|abcdefv
ENTRY = Disease Models, Autoimmune, Nervous System|T050|NON|EQV|NLM (2000)|991012|DIS MODELS AUTOIMMUNE NERVOUS SYSTEM|abcdefv
ENTRY = Glucuronic Acid, 6-(14)C-labeled, (D)-isomer|T109|NON|NRW|NLM (2013)|120207|abcdef
ENTRY = Parkinson Disease, Familial, Autosomal Recessive|T047|NON|NRW|NLM (2000)|991012|PARKINSON DIS FAMILIAL AUTOSOMAL RECESSIVE|abcdefv
ENTRY = Parkinson Disease, Juvenile, Autosomal Dominant|T047|EPO|NRW|NLM (2000)|991012|PARKINSON DIS JUVENILE AUTOSOMAL DOMINANT|abcdefv
ENTRY = Parkinson Disease, Juvenile, Autosomal Recessive|T047|EPO|NRW|OMIM (2013)|ORD (2010)|121212|abcdeef
ENTRY = Parkinsonism, Early Onset, with Diurnal Fluctuation|T047|EPO|NRW|ORD (2010)|121212|abcdef
ENTRY = Parkinsonism, Early-Onset, With Diurnal Fluctuation|T047|EPO|NRW|OMIM (2013)|111115|abcdef
ENTRY = Parkinsonism, Juvenile, Autosomal Dominant|T047|EPO|NRW|NLM (2000)|991012|abcdef
ENTRY = Parkinsonism, Juvenile, Autosomal Recessive|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Brain Diseases, Metabolic, Familial|T047|NON|NRW|NLM (2000)|991012|BRAIN DIS METAB FAMILIAL|abcdefv
ENTRY = Brain Diseases, Metabolic, Inherited|T047|NON|NRW|NLM (2000)|991012|BRAIN DIS METAB INHERITED|abcdefv
ENTRY = Brain Syndrome, Metabolic, Inborn|T047|NON|EQV|NLM (2000)|991012|BRAIN SYNDROME METAB INBORN|abcdefv
ENTRY = Encephalopathies, Metabolic, Inborn|T047|NON|EQV|NLM (2000)|991012|ENCEPH METAB INBORN|abcdefv
ENTRY = Metabolic Diseases, Inborn, Central Nervous System|T047|NON|BRD|NLM (2000)|991012|METAB DIS INBORN CNS|abcdefv
ENTRY = Metabolic Disorders, Brain, Inherited|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Metabolic Disorders, CNS, Inborn|T047|NON|BRD|NLM (2000)|991012|METAB DIS CNS INBORN|abcdefv
ENTRY = Metabolic Disorders, Familial, Brain|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Spinocerebellar Ataxia, Autosomal Dominant, with Sensory Axonal Neuropathy|T047|NON|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101214|abcdeeef
ENTRY = Embryonic Artery, Persistent, Cerebral|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Vascular Malformations, Congenital, Nervous System|T047|NON|NRW|NLM (2000)|991012|VASCULAR MALFORMATIONS CONGEN NERVOUS SYSTEM|abcdefv
ENTRY = Angioma, Venous, Central Nervous System|T019|NON|EQV|NLM (2000)|991012|ANGIOMA VENOUS CNS|abcdefv
ENTRY = Infections, CNS, Viral|T047|NON|EQV|NLM (2000)|991012|INFECT CNS VIRAL|abcdefv
ENTRY = Infections, Bacterial, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|INFECT BACTERIAL CNS|abcdefv
ENTRY = Infections, Central Nervous System, Parasitic|T047|NON|EQV|NLM (2000)|991012|INFECT CNS PARASITIC|abcdefv
ENTRY = Infections, Parasitic, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|INFECT PARASITIC CNS|abcdefv
ENTRY = Infection, Central Nervous System, Protozoal|T047|NON|EQV|NLM (2000)|991012|INFECT CNS PROTOZOAL|abcdefv
ENTRY = Infections, Protozoal, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|INFECT PROTOZOAL CNS|abcdefv
ENTRY = Enkephalin, Pen(2,5)-|T116|T121|NON|EQV|NLM (2000)|991012|abbcdef
ENTRY = Enkephalin, Penicillamine (2,5)-|T116|T121|NON|EQV|NLM (2000)|991012|abbcdef
ENTRY = Myopathy, Centronuclear, 1|T047|NON|REL|OMIM (2015)|151023|abcdef
ENTRY = Myopathy, Centronuclear, Autosomal Dominant|T047|REL|OMIM (2013)|111115|abdef
ENTRY = Myopathy, Congenital, With Fiber-Type Disproportion|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Convulsions, Benign Familial Infantile, 1|T047|NON|NRW|OMIM (2013)|ORD (2010)|121211|abcdeef
ENTRY = Convulsions, Benign Familial Infantile, 3|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Convulsions, Benign Neonatal, Familial|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Convulsions, Benign Neonatal, Non-Familial|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Epilepsy, Benign Neonatal, Familial|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Epilepsy, Benign Neonatal, Non-Familial|T047|NON|NRW|NLM (2008)|071031|abcdef
ENTRY = Epilepsy, Benign Neonatal, Nonfamilial|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Seizures, Benign Familial Infantile, 1|T047|NON|NRW|OMIM (2013)|ORD (2010)|121211|abcdeef
ENTRY = Seizures, Benign Familial Infantile, 3|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Seizure Disorder, Sensory, Focal|T047|NON|EQV|NLM (2000)|991012|SEIZURE DIS SENSORY FOCAL|abcdefv
ENTRY = Seizures, Simple Partial, Special Sensory Symptoms|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Myasthenia Gravis, Neonatal, Persistent|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Myasthenia Gravis, Neonatal, Transient|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Myasthenia Gravis, Persistent, Neonatal|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Myasthenia Gravis, Transient, Neonatal|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Amyotrophy, Hereditary Neuralgic, with Predilection for Brachial Plexus|T047|NON|REL|GHR (2014)|OMIM (2013)|ORD (2010)|130605|abcdeeef
ENTRY = Carcinoma, Ductal, Pancreatic|T191|NON|EQV|NLM (2009)|071022|abcdef
ENTRY = Measles, Mumps, Rubella Vaccine|T121|T129|NON|EQV|NLM (2001)|abbcde
ENTRY = Gonadal Dysgenesis, 46, XX|T019|T047|NON|EQV|NLM (2011)|100217|abbcdef
ENTRY = Pure Gonadal Dysgenesis, 46, XX|T019|T047|NON|NRW|NLM (2011)|100201|abbcdef
ENTRY = Pure Gonadal Dysgenesis, 46,XX|T019|T047|NON|NRW|NLM (2011)|100217|abbcdef
ENTRY = 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol|T109|T127|NON|EQV|NLM (2002)|001004|abbcdef
ENTRY = R,R,R-alpha-Tocopherol|T109|T127|NON|NRW|NLM (2014)|130418|abbcdef
ENTRY = 3,4-Dihydro-2,5,8-trimethyl-2-(4,8,12- trimethyltridecyl)-2H-1-benzopyran-6-ol|T109|T121|T127|NON|EQV|NLM (2002)|001004|abbbcdef
ENTRY = 3,4-Dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol|T109|T121|T127|NON|EQV|NLM (2009)|080701|abbbcdef
ENTRY = Glyceraldehyde-3-Phosphate Dehydrogenase, NADP, Phosphorylating|T116|T126|NON|EQV|NLM (2002)|001207|abbcdef
ENTRY = Glyceraldehyde-3-Phosphate Dehydrogenase, NADP-Dependent, Phosphorylating|T116|T126|NON|EQV|NLM (2002)|001013|abbcdef
ENTRY = Ergocornine, 9,10-dihydro-|T109|T121|T123|NON|EQV|NLM (2002)|001214|abbbcdef
ENTRY = Fructose-6-phosphate,2-kinase-fructose-2,6-bisphosphatase|T116|T126|NON|BRD|NLM (2002)|abbcde
ENTRY = (m-Phenoxybenzyl)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate|T109|T121|NON|EQV|NLM (2002)|abbcde
ENTRY = 3-Phenoxybenzyl-(+-)-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, ester|T109|T121|NON|EQV|NLM (2002)|abbcde
ENTRY = 3-Phenoxybenzyl-cis,trans-(1RS)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate|T109|T121|NON|EQV|NLM (2002)|abbcde
ENTRY = Solute Carrier Family 7-(Cationic Amino Acid Transporter, y+ System), Member 1|T116|T192|NON|EQV|NLM (2002)|010228|abbcdef
ENTRY = Solute-Carrier Family 7 (Cationic Amino Acid Transporter, y+ System), Member 2|T116|T123|NON|EQV|NLM (2002)|010228|abbcdef
ENTRY = Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 9|T116|T123|NON|NRW|NLM (2014)|130404|abbcdef
ENTRY = Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 10|T116|T123|NON|NRW|NLM (2014)|130404|abbcdef
ENTRY = Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 4|T116|T123|NON|NRW|NLM (2014)|130404|abbcdef
ENTRY = Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 5|T116|T123|NON|NRW|NLM (2014)|130404|abbcdef
ENTRY = Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 7|T116|T123|NON|NRW|NLM (2014)|130404|abbcdef
ENTRY = Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 8|T116|T123|NON|NRW|NLM (2014)|130404|abbcdef
ENTRY = Na(+), K(+), Cl(-)-Cotransporter|T116|T123|ACX|EQV|NLM (2002)|abbcde
ENTRY = Sodium, Potassium, Chloride-Cotransporter|T116|T123|NON|EQV|NLM (2002)|abbcde
ENTRY = Amyloidosis, Cerebroarterial, Icelandic Type|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cerebral Hemorrhage, Hereditary, With Amyloidosis|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Deficiency, Multiple Carboxylase, Late-Onset|T047|NON|EQV|NLM (2002)|010416|DEFIC MULTIPLE CARBOXYLASE LATE ONSET|abcdefv
ENTRY = Deficiency, Multiple Carboxylase, Neonatal Form|T047|NON|EQV|NLM (2002)|010416|DEFIC MULTIPLE CARBOXYLASE NEONATAL FORM|abcdefv
ENTRY = Optic Atrophy, Leber, Hereditary|T047|NON|EQV|NLM (2002)|010516|abcdef
ENTRY = Anemia, Congenital Hypoplastic, Of Blackfan And Diamond|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Red Cell Aplasia, Pure, Hereditary|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Deafness, Congenital, and Functional Heart Disease|T047|NON|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101201|abcdeeef
ENTRY = Fibroblast Virus, Human, Permanent|T005|NON|NRW|NLM (1994)|930224|abcdef
ENTRY = Nephropathy, Wilms Tumor, and Genital Anomalies|T019|T191|EPO|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101201|abbcdeeef
ENTRY = ADP, ATP Carrier Protein, Liver Isoform T2|T116|T123|ACX|EQV|NLM (2017)|151222|abbcdef
ENTRY = Dynamin, Mutated Form, K44A|T116|T123|ACX|NRW|NLM (2003)|011126|abbcdef
ENTRY = Sarcoma, Endometrial Stromal, Low-Grade|T191|NON|NRW|NLM (2003)|020208|abcdef
ENTRY = Lectin, Galactoside-Binding, Soluble, 4 Protein|T116|T123|NON|EQV|NLM (2003)|020131|abbcdef
ENTRY = TRF-1 Interacting, Ankyrin-Related, ADP-Ribose Polymerases|T116|T126|NON|EQV|NLM (2003)|020301|abbcdef
ENTRY = Homologs, 3-D, Protein|T087|NON|REL|NLM (2005)|030805|HOMOL 3D PROTEIN|abcdefv
ENTRY = Homologs, 3-Dimensional, Protein|T087|NON|REL|NLM (2005)|030805|HOMOL 3 DIMENSIONAL PROTEIN|abcdefv
ENTRY = Homologs, Sturctural, Protein|T087|NON|REL|NLM (2005)|030805|abcdef
ENTRY = Retinoschisis, Juvenile, X Chromosome-Linked|T047|NON|NRW|NLM (2003)|020712|abcdef
ENTRY = 3,20-Allopregnanedione, (5alpha)-Isomer|T109|T123|NON|EQV|NLM (2004)|990818|abbcdef
ENTRY = 3,20-Allopregnanedione, (5beta,13alpha,17alpha)-Isomer|T109|T123|NON|REL|NLM (2004)|990818|abbcdef
ENTRY = 1,2,3,4-Tetrahydroisoquinolines|T109|NON|EQV|NLM (2004)|021230|abcdef
ENTRY = Receptor, Melatonin, 1C|T116|T192|NON|NRW|NLM (2004)|030106|RECEPT MELATONIN 1C|abbcdefv
ENTRY = Receptor, Melatonin, MT3|T116|T192|NON|NRW|NLM (2004)|030106|RECEPT MELATONIN MT3|abbcdefv
ENTRY = Receptor, Serotonin, 5-HT3 Subunit A|T116|T192|ABX|NRW|NLM (2011)|100107|abbcdef
ENTRY = Receptor, Serotonin, 5-HT3 Subunit B|T116|T192|ABX|NRW|NLM (2011)|100107|abbcdef
ENTRY = Receptor, Serotonin, 5-HT3 Subunit C|T116|T192|ABX|NRW|NLM (2011)|100107|abbcdef
ENTRY = Receptor, Serotonin, 5-HT3 Subunit D|T116|T192|ABX|NRW|NLM (2011)|100107|abbcdef
ENTRY = Receptor, Serotonin, 5-HT3 Subunit E|T116|T192|ABX|NRW|NLM (2011)|100107|abbcdef
ENTRY = Receptor, Serotonin, 5-HT3A|T116|T192|ABX|NRW|NLM (2004)|030124|RECEPT SEROTONIN 5 HT3A|abbcdefv
ENTRY = Receptor, Serotonin, 5-HT3B|T116|T192|ABX|NRW|NLM (2004)|030124|RECEPT SEROTONIN 5 HT3B|abbcdefv
ENTRY = Receptor, Serotonin, 5-HT3C|T116|T192|ABX|NRW|NLM (2011)|100107|abbcdef
ENTRY = Receptor, Serotonin, 5-HT3D|T116|T192|NON|NRW|NLM (2011)|100107|abbcdef
ENTRY = Receptor, Serotonin, 5-HT3E|T116|T192|ABX|NRW|NLM (2011)|100107|abbcdef
ENTRY = Polyposis, Skin Pigmentation, Alopecia, And Fingernail Changes|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Hyperinsulinemic Hypoglycemia, Familial, 1|T047|NON|NRW|OMIM (2013)|ORD (2010)|121210|abcdeef
ENTRY = Hyperinsulinemic Hypoglycemia, Familial, 2|T047|NON|NRW|OMIM (2013)|ORD (2010)|121210|abcdeef
ENTRY = Hypoglycemia, Hyperinsulinemic, of Infancy|T047|NON|EQV|OMIM (2013)|120210|abcdef
ENTRY = Respiratory Syndrome, Acute, Severe|T047|NON|EQV|NLM (2003)|030324|abcdef
ENTRY = 2,7,9-Tricarboxy-1H-Pyrrolo-(2,3-f)Quinoline-4,5-Dione|T109|T123|NON|EQV|NLM (2004)|abbcde
ENTRY = 2,7,9-Tricarboxypyrroloquinoline Quinone|T109|T123|NON|EQV|NLM (2004)|abbcde
ENTRY = 4,5-Dihydro-4,5-Dioxo-1-H-Pyrrolo(2,3-f)Quinoline-2,7,9-Tricarboxylic Acid|T109|T123|NON|EQV|NLM (2004)|abbcde
ENTRY = 1,2,4,5-Tetraoxanes|T109|NON|NRW|NLM (2004)|030430|abcdef
ENTRY = Hematoma, Subdural, Cranial|T020|T037|NON|EQV|NLM (2005)|031021|abbcdef
ENTRY = Subdural Hematoma, Traumatic, Intracranial|T020|T037|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Subdural Hematoma, Spinal, Traumatic|T020|T037|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = 3',4',5,7-Tetrahydroxy-Flavone|T109|NON|EQV|NLM (2005)|020607|abcdef
ENTRY = 3',4',5,7-Tetrahydroxyflavone|T109|NON|EQV|NLM (2005)|abcde
ENTRY = Stimulators, Electrical, Cardiac, Shock|T074|NON|EQV|NLM (2005)|031222|abcdef
ENTRY = Chernobyl Nuclear Accident, Chornobyl, Ukraine, 1986|T078|NON|EQV|NLM (2005)|040128|abcdef
ENTRY = Hemangioma, Sclerosing, Pulmonary|T191|NON|EQV|NLM (2005)|040303|HEMANGIOMA SCLEROSING PULM|abcdefv
ENTRY = Muscular Dystrophy, Distal, Late-Onset, Autosomal Dominant|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Myopathy, Distal, Early-Onset, Autosomal Dominant|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Myopathy, Distal, Swedish|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Immunodeficiency, Microcephaly, And Chromosomal Instability|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Microcephaly with Normal Intelligence, Immunodeficiency, and Lymphoreticular Malignancies|T047|NON|EQV|OMIM (2013)|ORD (2010)|130503|abcdeef
ENTRY = Nonsyndromal Microcephaly, Autosomal Recessive, with Normal Intelligence|T047|NON|EQV|OMIM (2013)|ORD (2010)|130503|abcdeef
ENTRY = Potassium-Sensitive Periodic Paralysis, Ventricular Ectopy, and Dysmorphic Features|T047|NON|EQV|NLM (2012)|ORD (2010)|101229|abcdeef
ENTRY = 46,XX Gonadal Dysgenesis, Complete, Sry-Positive|T019|T047|NON|EQV|OMIM (2013)|121212|abbcdef
ENTRY = 46,XX True Hermaphroditism, Sry-Positive|T019|T047|NON|EQV|OMIM (2013)|121212|abbcdef
ENTRY = beta, beta-Carotene-15,15'-Dioxygenase|T116|T126|NON|EQV|NLM (2006)|010705|abbcdef
ENTRY = beta, beta-Carotene-15,15'-Monooxygenase|T116|T126|NON|EQV|NLM (2006)|030122|abbcdef
ENTRY = POU Domain, Class 5, Transcription Factor 1|T116|T123|ABX|EQV|NLM (2006)|040915|abbcdef
ENTRY = POU Domain, Class 4, Transcription Factor 1|T116|T123|ABX|EQV|NLM (2006)|041017|abbcdef
ENTRY = POU Domain, Class 4, Transcription Factor 2|T116|T123|ABX|EQV|NLM (2006)|041017|abbcdef
ENTRY = POU Domain, Class 4, Transcription Factor 3|T116|T123|ABX|EQV|NLM (2006)|041017|abbcdef
ENTRY = Scavenger Receptors, Class A, Type I|T116|NON|NRW|NLM (2006)|050113|abcdef
ENTRY = Scavenger Receptors, Class A, Type I-II|T116|NON|NRW|NLM (2006)|050114|abcdef
ENTRY = Scavenger Receptors, Class A, Type II|T116|NON|NRW|NLM (2006)|050113|abcdef
ENTRY = Receptor, LDL, Oxidized|T116|T192|ABX|EQV|NLM (2006)|abbcde
ENTRY = Solute Carrier Family 2, Facilitated Glucose Transporter, Member 1 Protein|T116|T123|NON|EQV|NLM (2006)|041010|abbcdef
ENTRY = Solute Carrier Family 2, Facilitated Glucose Transporter, Member 2 Protein|T116|T123|NON|EQV|NLM (2006)|041017|abbcdef
ENTRY = Solute Carrier Family 2, Facilitated Glucose Transporter, Member 3 Protein|T116|T123|NON|EQV|NLM (2006)|040930|abbcdef
ENTRY = Solute Carrier Family 2, Facilitated Glucose Transporter, Member 4 Protein|T116|T123|NON|EQV|NLM (2006)|050128|abbcdef
ENTRY = Hemophagocytic Lymphohistiocytosis, Familial, 1|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Sterility, Reproductive, Plants|T045|NON|EQV|NLM (2006)|050421|abcdef
ENTRY = Nuclear Receptor Subfamily 2, Group A, Member 1|T116|T192|NON|NRW|NLM (2010)|090417|abbcdef
ENTRY = Nuclear Receptor Subfamily 2, Group F, Member 2|T116|T192|NON|EQV|NLM (2010)|090415|abbcdef
ENTRY = Research, NIH, Intramural|T064|NON|EQV|NLM (2005)|050404|abcdef
ENTRY = United States Gov't Supported, P.H.S., N.I.H., Intramural|T064|NON|EQV|NLM (2005)|050404|abcdef
ENTRY = Research, NIH, Extramural|T064|NON|EQV|NLM (2005)|050404|abcdef
ENTRY = United States Gov't Supported, P.H.S., N.I.H., Extramural|T064|NON|EQV|NLM (2005)|050404|abcdef
ENTRY = Usher Syndrome, Type I, French Variety|T047|EPO|NRW|ORD (2010)|120620|abcdef
ENTRY = Abetalipoproteinemia, Normotriglyceridemic, Steinbert Type|T047|NON|EQV|NLM (2007)|050720|abcdef
ENTRY = Hypobetalipoproteinemia, Familial, Apo B|T047|NON|EQV|NLM (2007)|050720|abcdef
ENTRY = Lipodystrophy, Familial Partial, Associated With PPARg Mutations|T047|ABX|NRW|OMIM (2013)|120209|abcdef
ENTRY = Lipodystrophy, Familial Partial, Dunnigan Type|T047|EPO|NRW|NLM (2007)|OMIM (2013)|ORD (2010)|050725|abcdeeef
ENTRY = Lipodystrophy, Familial Partial, Kobberling Type|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Lipodystrophy, Familial Partial, Type 1|T047|NON|NRW|NLM (2007)|OMIM (2013)|050725|abcdeef
ENTRY = Lipodystrophy, Familial Partial, Type 2|T047|NON|NRW|NLM (2007)|OMIM (2013)|ORD (2010)|050725|abcdeeef
ENTRY = Lipodystrophy, Familial Partial, Type 3|T047|NON|NRW|NLM (2007)|OMIM (2013)|050725|abcdeef
ENTRY = Lipodystrophy, Familial, of Limbs and Lower Trunk|T047|NON|NRW|OMIM (2013)|120209|abcdef
ENTRY = Lipodystrophy, Berardinelli-Seip Congenital, Type 1|T047|EPO|NRW|OMIM (2013)|111115|abcdef
ENTRY = Lipodystrophy, Berardinelli-Seip Congenital, Type 2|T047|EPO|NRW|OMIM (2013)|111115|abcdef
ENTRY = Lipodystrophy, Congenital Generalized, Type 1|T047|NON|NRW|NLM (2007)|OMIM (2013)|050725|abcdeef
ENTRY = Lipodystrophy, Congenital Generalized, Type 2|T047|NON|NRW|NLM (2007)|OMIM (2013)|050725|abcdeef
ENTRY = Lipodystrophy, Total, And Acromegaloid Gigantism|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Sulfatidosis, Juvenile, Austin Type|T047|EPO|NRW|NLM (2007)|OMIM (2013)|050729|abcdeef
ENTRY = Influenza Virus, Canine, H3N2 Subtype|T005|NON|EQV|NLM (2014)|130531|abcdef
ENTRY = Influenza Virus, Canine, H3N8 Subtype|T005|NON|EQV|NLM (2014)|130531|abcdef
ENTRY = Influenza Virus, Equine, H3N8 Subtype|T005|NON|EQV|NLM (2014)|130531|abcdef
ENTRY = Receptors, Tumor Necrosis Factor, Member 10a|T116|T192|NON|NRW|NLM (2007)|051205|abbcdef
ENTRY = Receptors, Tumor Necrosis Factor, Member 10d|T116|T192|NON|NRW|NLM (2007)|051205|abbcdef
ENTRY = 2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid|T109|T121|NON|EQV|NLM (2007)|abbcde
ENTRY = 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid|T109|T121|NON|EQV|NLM (2007)|abbcde
ENTRY = 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid|T109|T121|NON|EQV|NLM (2007)|abbcde
ENTRY = 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid|T109|T121|NON|EQV|NLM (2007)|000202|abbcdef
ENTRY = Ectodermal Dysplasia, Anhidrotic, X-Linked|T019|T047|NON|EQV|OMIM (2013)|111115|abbcdef
ENTRY = Ectodermal Dysplasia, Hypohidrotic, X-Linked|T019|T047|NON|EQV|OMIM (2013)|111115|abbcdef
ENTRY = Ectodermal Dysplasia, Hypohydridic, X-Linked|T019|T047|NON|EQV|NLM (2007)|051209|abbcdef
ENTRY = Ectodermal Dysplasia, Hypohidrotic, Autosomal Dominant|T019|T047|NON|EQV|NLM (2007)|OMIM (2013)|051209|abbcdeef
ENTRY = Ectodermal Dysplasia, Anhidrotic, Autosomal Recessive|T019|T047|NON|EQV|NLM (2007)|051209|abbcdef
ENTRY = Ectodermal Dysplasia, Hypohydrotic, Autosomal Recessive|T019|T047|NON|EQV|NLM (2007)|060127|abbcdef
ENTRY = 5-beta-Cholestane-3-alpha,7-alpha,12-alpha-triol 27-Hydroxylase|T116|T126|NON|EQV|NLM (2007)|020715|abbcdef
ENTRY = 1,4,5-INTP Receptor|T116|T192|ABX|EQV|NLM (2007)|abbcde
ENTRY = Inositol 1,4,5-trisphosphate Receptor Subtype 3|T116|T192|NON|NRW|NLM (2007)|abbcde
ENTRY = Inositol 1,4,5-trisphosphate Receptor Type 1|T116|T192|NON|NRW|NLM (2007)|040521|abbcdef
ENTRY = Inositol 1,4,5-trisphosphate Receptor Type 2|T116|T192|NON|NRW|NLM (2007)|040521|abbcdef
ENTRY = Inositol 1,4,5-trisphosphate Receptor Type 3|T116|T192|NON|NRW|NLM (2007)|040521|abbcdef
ENTRY = Inositol-1,4,5-Triphosphate Receptor|T116|T192|NON|EQV|NLM (2007)|abbcde
ENTRY = Receptor, Inositol-1,4,5-triphosphate|T116|T192|NON|EQV|NLM (2007)|abbcde
ENTRY = Type 1 Inositol 1,4,5-trisphosphate Receptor|T116|T192|NON|NRW|NLM (2007)|abbcde
ENTRY = Type 3 Inositol 1,4,5-trisphosphate Receptor|T116|T192|NON|NRW|NLM (2007)|060111|abbcdef
ENTRY = Sodium Channel, Nonvoltage-gated 1 Protein, alpha Subunit|T116|T123|NON|NRW|NLM (2007)|050502|abbcdef
ENTRY = Sodium Channel, Nonvoltage-gated 1 Protein, beta Subunit|T116|T123|NON|NRW|NLM (2007)|050502|abbcdef
ENTRY = Sodium Channel, Nonvoltage-gated 1 Protein, delta Subunit|T116|T123|NON|NRW|NLM (2007)|050502|abbcdef
ENTRY = Sodium Channel, Nonvoltage-gated 1 Protein, gamma Subunit|T116|T123|NON|NRW|NLM (2007)|050502|abbcdef
ENTRY = Hypokalemia-Hypomagnesemia, Primary Renotubular, with Hypocalciuria|T047|NON|EQV|GHR (2014)|NLM (2010)|090406|abcdeef
ENTRY = Hypomagnesemia-Hypokalemia, Primary Renotubular, with Hypocalciuria|T047|NON|EQV|NLM (2007)|OMIM (2013)|ORD (2010)|060208|abcdeeef
ENTRY = Severe Combined Immunodeficiency, X-Linked, T Cell Negative, B Cell Positive, NK Cell Negative|T047|NON|EQV|ORD (2010)|121205|abcdef
ENTRY = Severe Combined Immunodeficiency, X-Linked, T Cell-Negative, B Cell-Positive, NK Cell-Negative|T047|NON|EQV|OMIM (2013)|121205|abcdef
ENTRY = alpha-subunit, Receptor, Interleukin-2|T116|T192|NON|EQV|NLM (2007)|011116|abbcdef
ENTRY = GM-CSF, IL-3, IL-5 Receptor Common beta-Chain|T116|T192|ABX|EQV|NLM (2007)|060222|abbcdef
ENTRY = Interleukin-3, 5, GM-CSF Receptor beta Subunit|T116|T192|ABX|EQV|NLM (2007)|060222|abbcdef
ENTRY = Receptors, Cytokine, Common beta Chain|T116|T192|NON|EQV|NLM (2007)|060301|abbcdef
ENTRY = alpha-Subunit, Receptor, Interleukin-3|T116|T192|NON|EQV|NLM (2007)|060222|abbcdef
ENTRY = Receptor, Interleukin-4, alpha Subunit|T116|T192|NON|EQV|NLM (2007)|060301|abbcdef
ENTRY = alpha-subunit, Receptor, Interleukin-4|T116|T192|NON|EQV|NLM (2007)|060227|abbcdef
ENTRY = Receptor, Interleukin-5, alpha Subunit|T116|T192|NON|EQV|NLM (2007)|060301|abbcdef
ENTRY = alpha-Subunit, Receptor, Interleukin-5|T116|T192|NON|EQV|NLM (2007)|060301|abbcdef
ENTRY = Receptor, Oncostatin M, beta Subunit|T116|T192|NON|EQV|NLM (2007)|060314|abbcdef
ENTRY = alpha-subunit, Receptor, Interleukin-11|T116|T192|NON|EQV|NLM (2007)|060306|abbcdef
ENTRY = alpha-Subunit, Receptor, Interleukin-15|T116|T192|NON|EQV|NLM (2007)|060221|abbcdef
ENTRY = Suppressor Factor, T-Cell, Glioblastoma-Derived|T116|T123|NON|EQV|NLM (2007)|900227|abbcdef
ENTRY = Movement Proteins, Virus, Plant|T116|T123|NON|EQV|NLM (2007)|060405|abbcdef
ENTRY = Right Bundle Branch Block, St Segment Elevation, And Sudden Death Syndrome|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Heterotopia, Periventricular, X-Linked Dominant|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Leukemia, Lymphoblastic, Acute|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphoblastic, Acute, L1|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphoblastic, Acute, L2|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphoblastic, Acute, Philadelphia-Positive|T191|NON|REL|NLM (1995)|940314|abcdef
ENTRY = Leukemia, Lymphocytic, Acute|T191|NON|EQV|NLM (1989)|990101|abcdef
ENTRY = Leukemia, Lymphocytic, Acute, L1|T191|NON|REL|NLM (1989)|990101|abcdef
ENTRY = Leukemia, Lymphocytic, Acute, L2|T191|NON|REL|NLM (1989)|990101|abcdef
ENTRY = Lymphoblastic Leukemia, Acute, Adult|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Lymphoblastic Leukemia, Acute, Childhood|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Lymphoblastic Leukemia, Acute, L1|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Lymphoblastic Leukemia, Acute, L2|T191|NON|REL|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphoblastic, Acute, T Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphocytic, Acute T Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Lymphoblastic Leukemia, Acute, T Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Lymphocytic Leukemia, T Cell, Acute|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Lissencephaly, X-Linked, 1|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Leukemia, Myelogenous, Ph1 Negative|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myelogenous, Ph1-Negative|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Chronic, Atypical|T191|NON|EQV|NLM (2008)|070112|abcdef
ENTRY = Leukemia, Myeloid, Ph1 Negative|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Ph1-Negative|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Myeloid, Philadelphia Negative|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Ichthyosis, Brittle Hair, Intellectual Impairment, Decreased Fertility, and Short Stature|T047|NON|NRW|NLM (2011)|ORD (2010)|100309|abcdeef
ENTRY = National Heart, Lung, and Blood Institute|T093|NAM|EQV|NLM (2008)|070130|abcdef
ENTRY = Protein Tyrosine Phosphatase, Non-Receptor Type 2, TC45 Isoform|T116|T126|ABX|NRW|NLM (2008)|070131|abbcdef
ENTRY = Protein Tyrosine Phosphatase, Non-Receptor Type 2, TC48 Isoform|T116|T126|NON|NRW|NLM (2008)|070131|abbcdef
ENTRY = Receptor-Like Protein Tyrosine Phosphatases, Class 1,6|T116|T126|NON|EQV|NLM (2008)|070205|abbcdef
ENTRY = Protein Tyrosine Phosphatase, Receptor Type, S|T116|T123|T126|NON|NRW|NLM (2008)|070206|abbbcdef
ENTRY = Protein Tyrosine Phosphatase, Receptor, Type M|T116|T126|NON|NRW|NLM (2008)|070205|abbcdef
ENTRY = Protein Tyrosine Phosphatase, Receptor Type, G|T116|T126|NON|NRW|NLM (2008)|070126|abbcdef
ENTRY = Protein Tyrosine Phosphatase, Receptor-Type, N|T116|T126|NON|NRW|NLM (2008)|abbcde
ENTRY = Protein Phosphatase 1, Catalytic Subunit, alpha Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 1, Catalytic Subunit, beta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 1, Catalytic Subunit, delta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 1, Catalytic Subunit, gamma Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 1, Catalytic Subunit, gamma1 Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 1, Catalytic Subunit, gamma2 Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2, Catalytic Subunit, alpha Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2, Catalytic Subunit, beta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2, Regulatory Subunit A, alpha Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2, Regulatory Subunit A, beta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2, Regulatory Subunit B, alpha Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2, Regulatory Subunit B, beta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2, Regulatory Subunit B, delta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2, Regulatory Subunit B, gamma Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2A, Catalytic Subunit, alpha Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2A, Catalytic Subunit, beta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2A, Regulatory Subunit A , alpha Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2A, Regulatory Subunit A, beta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2A, Regulatory Subunit B, alpha Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2A, Regulatory Subunit B, beta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2A, Regulatory Subunit B, delta Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Protein Phosphatase 2A, Regulatory Subunit B, gamma Isoform|T116|T126|NON|NRW|NLM (2008)|070212|abbcdef
ENTRY = Ribosomal Subunits, 30S, Bacterial|T026|NON|EQV|NLM (2008)|070221|abcdef
ENTRY = Ribosomal Subunits, Small, Bacterial|T026|NON|EQV|NLM (2008)|070221|abcdef
ENTRY = Ribosome Subunits, 30S, Bacterial|T026|NON|EQV|NLM (2008)|070221|abcdef
ENTRY = Ribosomal Subunits, 50S, Bacterial|T026|NON|EQV|NLM (2008)|070221|abcdef
ENTRY = Ribosomal Subunits, Large, Bacterial|T026|NON|EQV|NLM (2008)|070221|abcdef
ENTRY = Ribosome Subunits, 50S, Bacterial|T026|NON|EQV|NLM (2008)|070221|abcdef
ENTRY = Ribosomal Subunits, Small, Eukaryotic|T026|NON|EQV|NLM (2008)|070221|abcdef
ENTRY = Ribosomal Subunits, Large, Eukaryotic|T026|NON|EQV|NLM (2008)|070221|abcdef
ENTRY = cGMP-Binding, cGMP-Specific 3',5'-cyclic Nucleotide Phosphodiesterase|T116|T126|ABX|EQV|NLM (2008)|abbcde
ENTRY = Cyclic Nucleotide Phosphodiesterases, Type 6, alpha Subunit|T116|T126|NON|NRW|NLM (2008)|070226|abbcdef
ENTRY = Cyclic Nucleotide Phosphodiesterases, Type 6, beta Subunit|T116|T126|NON|NRW|NLM (2008)|070223|abbcdef
ENTRY = Cyclic Nucleotide Phosphodiesterases, Type 6, delta Subunit|T116|T126|NON|NRW|NLM (2008)|070223|abbcdef
ENTRY = Cyclic Nucleotide Phosphodiesterases, Type 6, gamma Subunit|T116|T126|NON|NRW|NLM (2008)|070223|abbcdef
ENTRY = Ribosomal Subunits, 50S, Archaeal|T026|NON|EQV|NLM (2008)|070307|abcdef
ENTRY = Ribosomal Subunits, Large, Archaeal|T026|NON|EQV|NLM (2008)|070307|abcdef
ENTRY = Ribosome Subunits, 50S, Archaeal|T026|NON|EQV|NLM (2008)|070307|abcdef
ENTRY = Ribosomal Subunits, 30S, Archaeal|T026|NON|EQV|NLM (2008)|070307|abcdef
ENTRY = Ribosomal Subunits, Small, Archaeal|T026|NON|EQV|NLM (2008)|070307|abcdef
ENTRY = Ribosome Subunits, 30S, Archaeal|T026|NON|EQV|NLM (2008)|070307|abcdef
ENTRY = Propoxyphene Hydrochloride, (R*,S*)-(+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Propoxyphene, (R*,S*)-(+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Propoxyphene, (R-(R*,S*))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Mental Retardation, Unusual Facies, And Intrauterine Growth Retardation|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Adrenal Hyperplasia, Congenital, Due To Cytochrome P450 Oxidoreductase Deficiency|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Osteodysgenesis, Multisynostotic, With Fractures|T047|NON|NRW|OMIM (2013)|ORD (2010)|111115|abcdeef
ENTRY = Fatty Acid Synthase, Bacterial, Plant, and Fungi Form|T116|T126|NON|EQV|NLM (2014)|130304|abbcdef
ENTRY = Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly|T047|NON|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101222|abcdeeef
ENTRY = Hallux Duplication, Postaxial Polydactyly, and Absence of Corpus Callosum|T047|NON|EQV|OMIM (2013)|120622|abcdef
ENTRY = Colon Cancer, Familial Nonpolyposis, Type 2|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Colorectal Cancer, Hereditary Nonpolyposis, Type 2|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Pustulosis, Exanthematous, Acute Generalized|T047|NON|EQV|NLM (2010)|090115|abcdef
ENTRY = Pustulosis, Exanthematous, Acute Localized|T047|NON|REL|NLM (2010)|090115|abcdef
ENTRY = Erythrokeratodermia Figurata, Congenital Familial, in Plaqus|T019|T047|NON|EQV|OMIM (2013)|ORD (2010)|151223|abbcdeef
ENTRY = Liver Injury, Drug-Induced, Acute|T037|NON|NRW|NLM (2014)|130103|abcdef
ENTRY = Hepatitis, Chronic, Drug-Induced|T047|NON|REL|NLM (1998)|990101|HEPATITIS CHRONIC DRUG IND|abcdefv
ENTRY = Hepatitis, Chronic, Drug-Related|T047|NON|REL|NLM (1998)|961112|HEPATITIS CHRONIC DRUG RELAT|abcdefv
ENTRY = Chronic Infantile Neurologic, Cutaneous, and Articular Syndrome|T047|NON|NRW|GHR (2014)|130418|abcdef
ENTRY = Chronic Neurologic, Cutaneous, and Articular Syndrome|T047|NON|NRW|GHR (2014)|130418|abcdef
ENTRY = Chronic, Infantile, Neurological, Cutaneous, Articular Syndrome|T047|NON|NRW|NLM (2011)|ORD (2010)|100401|abcdeef
ENTRY = Pineal Hyperplasia, Insulin-Resistant Diabetes Mellitus, And Somatic Abnormalities|T019|T047|NON|REL|OMIM (2013)|111115|abbcdef
ENTRY = LAMB - Lentigines, Atrial Myxoma, Mucocutaneous Myoma, Blue Nevus Syndrome|T047|ABX|EQV|GHR (2014)|130502|abcdef
ENTRY = Nevi, Atrial Myxoma, Skin Myxoma, Ephelides Syndrome|T047|NON|EQV|GHR (2014)|130502|abcdef
ENTRY = Autoimmune Lymphoproliferative Syndrome, Type I, Autosomal Dominant|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Neuropathy, Giant Axonal, Autosomal Recessive|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Angioedema, Hereditary, Type III|T046|NON|EQV|OMIM (2013)|120606|abcdef
ENTRY = Angioneurotic Edema, Hereditary, with Normal C1 Inhibitor Concentration and Function|T046|NON|EQV|NLM (2013)|120606|abcdef
ENTRY = Angioedema, Hereditary, Type I|T019|T047|NON|NRW|OMIM (2013)|ORD (2010)|090209|abbcdeef
ENTRY = Angioedema, Hereditary, Type II|T019|T047|NON|NRW|NLM (2010)|OMIM (2013)|090209|abbcdeef
ENTRY = Angioedema, Hereditary, Types I and II|T047|NON|EQV|NLM (2010)|090209|abcdef
ENTRY = Nuclear Receptor Subfamily 0, Group B, Member 1|T116|T192|NON|EQV|NLM (2010)|090417|abbcdef
ENTRY = Dementia, Frontotemporal, with Parkinsonism|T048|NON|EQV|OMIM (2013)|ORD (2010)|090423|abcdeef
ENTRY = Foveomacular Dystrophy, Adult-Onset, With Choroidal Neovascularization|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Macular Dystrophy, Vitelliform, Adult-Onset|T047|NON|NRW|OMIM (2013)|120618|abcdef
ENTRY = Cold, Flu, and Allergy Medications, Multi-Ingredient|T121|ABX|EQV|NLM (2011)|091223|abcdef
ENTRY = Muscular Dystrophy, Limb-Girdle, Type 2D|T047|NON|NRW|OMIM (2013)|120613|abcdef
ENTRY = Purinergic Receptor P2Y, G-Protein Coupled, 1|T116|T192|NON|EQV|NLM (2011)|100114|abbcdef
ENTRY = Puringergic Receptor P2Y, G-Protein Coupled, 2|T116|T192|ABX|EQV|NLM (2011)|100114|abbcdef
ENTRY = Purinergic Receptor P2X, Ligand-Gated Ion Channel, 1|T116|T192|ABX|EQV|NLM (2011)|100114|abbcdef
ENTRY = Purinergic Receptor P2X, Ligand-Gated Ion Channel, 2|T116|T192|ABX|EQV|NLM (2011)|100115|abbcdef
ENTRY = Purinergic Receptor P2X, Ligand-Gated Ion Channel, 3|T116|T192|ABX|EQV|NLM (2011)|100115|abbcdef
ENTRY = Purinergic Receptor P2X, Ligand-Gated Ion Channel, 5|T116|T192|ABX|EQV|NLM (2011)|100119|abbcdef
ENTRY = Purinergic Receptor P2X, Ligand-Gated Ion Channel, 7|T116|T192|ABX|EQV|NLM (2011)|100119|abbcdef
ENTRY = 46,XY Gonadal Dysgenesis, Complete or Partial, With or Without Adrenal Failure|T047|NON|NRW|OMIM (2013)|121211|abcdef
ENTRY = 46,XY Sex Reversal, Partial or Complete, NR5A1-Related|T047|NON|NRW|OMIM (2013)|121211|abcdef
ENTRY = Disorder of Sex Development, 46,XY|T047|NON|NRW|OMIM (2013)|121211|abcdef
ENTRY = Sex Reversal, XY, With Or Without Adrenal Failure|T047|NON|NRW|OMIM (2013)|121211|abcdef
ENTRY = Hydrocephalus, Agyria, And Retinal Dysplasia|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Muscular Dystrophy, Limb-Girdle, Autosomal Recessive, With Mental Retardation|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Muscular Dystrophy, Limb-Girdle, Type 2K|T047|NON|REL|NLM (2013)|120612|abcdef
ENTRY = Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 1|T047|NON|EQV|NLM (2014)|OMIM (2013)|130318|abcdeef
ENTRY = Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle), Type C, 1|T047|NON|REL|NLM (2014)|130318|abcdef
ENTRY = Lymphoma, T-Cell, Enteropathy-Associated|T191|NON|EQV|NLM (2011)|100304|abcdef
ENTRY = Gonadal Sex Reversal, 46, XX|T019|T047|NON|NRW|NLM (2011)|100202|abbcdef
ENTRY = Sex Reversal, Gonadal, 46, XX|T019|T047|NON|NRW|NLM (2011)|100202|abbcdef
ENTRY = Corpus Callosum, Agenesis Of, With Chorioretinal Abnormality|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Phosphoinositide-3-Kinase, Class 2, alpha Polypeptide|T116|T126|NON|NRW|NLM (2011)|100201|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Class 2, beta Polypeptide|T116|T126|NON|NRW|NLM (2011)|100201|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Class 2, gamma Polypeptide|T116|T126|NON|NRW|NLM (2011)|100201|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Class II, alpha Polypeptide|T116|T126|NON|NRW|NLM (2011)|100201|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Class II, beta Polypeptide|T116|T126|NON|NRW|NLM (2011)|100201|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Class II, gamma Polypeptide|T116|T126|NON|NRW|NLM (2011)|100201|abbcdef
ENTRY = Class Ia Phosphatidylinositol 3-kinase, Regulatory, alpha Polypeptide|T116|T123|NON|NRW|NLM (2011)|100129|abbcdef
ENTRY = Class Ia Phosphatidylinositol 3-kinase, Regulatory, beta Polypeptide|T116|T123|NON|NRW|NLM (2011)|100129|abbcdef
ENTRY = Class Ia Phosphatidylinositol 3-kinase, Regulatory, gamma Polypeptide|T116|T123|NON|NRW|NLM (2011)|100129|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Catalytic, alpha Polypeptide|T116|T126|NON|NRW|NLM (2011)|100128|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Catalytic, beta Polypeptide|T116|T126|NON|NRW|NLM (2011)|100128|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Catalytic, delta Polypeptide|T116|T126|NON|NRW|NLM (2011)|100128|abbcdef
ENTRY = Phosphoinositide-3-Kinase, Catalytic, gamma Polypeptide|T116|T126|NON|NRW|NLM (2011)|100129|abbcdef
ENTRY = Phosphatidylinositol 3-Kinase, Regulatory Subunit, Polypeptide 4, p150|T116|T126|NON|EQV|NLM (2011)|100202|abbcdef
ENTRY = CHARGE Association--Coloboma, Heart Anomaly, Choanal Atresia, Retardation, Genital and Ear Anomalies|T047|NON|EQV|OMIM (2013)|120803|abcdef
ENTRY = Leucovorin, Calcium (1:1) Salt, (S)-Isomer|T109|T121|T127|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Leucovorin, Monopotassium Salt, (S)-Isomer|T109|T121|T127|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Leucovorin, Monosodium Salt, (S)-Isomer|T109|T121|T127|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Purinergic Receptor P2X, Ligand-Gated Ion Channel, 4|T116|T192|ABX|EQV|NLM (2011)|100330|abbcdef
ENTRY = Purinergic Receptor P2Y, G-Protein Coupled, 12|T116|T192|ABX|EQV|NLM (2017)|160211|abbcdef
ENTRY = Receptors, Folate, GPI-Anchored|T116|T192|ABX|EQV|NLM (2011)|100416|abbcdef
ENTRY = Arthroplasty, Replacement, Disc|T061|NON|EQV|NLM (2012)|100715|abcdef
ENTRY = Arthroplasty, Replacement, Disk|T061|NON|EQV|NLM (2012)|101029|abcdef
ENTRY = Phaeohyphomycosis, Central Nervous System, Primary|T047|NON|NRW|NLM (2012)|110125|abcdef
ENTRY = Receptors, Costimulatory and Inhibitory, T-Lymphocyte|T116|T129|T192|NON|EQV|NLM (2012)|110329|abbbcdef
ENTRY = Receptors, Costimulatory, T-Lymphocyte|T116|T129|NON|NRW|NLM (2012)|110329|abbcdef
ENTRY = Receptors, Inhibitory, T-Cell|T116|T129|NON|NRW|NLM (2012)|110329|abbcdef
ENTRY = Insulin, Regular, Porcine|T116|T121|T125|NON|EQV|NLM (2012)|110504|abbbcdef
ENTRY = Insulin, Lente, Monocomponent|T116|T121|NON|NRW|UNK (19XX)|820226|abbcdef
ENTRY = Sodium Channel, Voltage-Gated, Type I, alpha Protein|T116|T123|NON|NRW|NLM (2013)|111130|abbcdef
ENTRY = Sodium Channel, Voltage-Gated, Type II, alpha 1|T116|T123|NON|NRW|NLM (2013)|111130|abbcdef
ENTRY = Sodium Channel, Voltage-Gated, Type II, alpha 1 Subunit|T116|T123|NON|NRW|NLM (2013)|111130|abbcdef
ENTRY = Sodium Channel, Voltage-Gated, Type IV, alpha 1 Subunit|T116|T123|NON|NRW|NLM (2013)|111130|abbcdef
ENTRY = Sodium Channel, Voltage-Gated, Type V, alpha Subunit|T116|T123|NON|NRW|NLM (2013)|111202|abbcdef
ENTRY = Adenovirus Type 4 and Type 7 Vaccine, Live, Oral|T121|T129|NON|NRW|NLM (2013)|120208|abbcdef
ENTRY = Adenovirus Type 4 and Type 7 Vaccines, Live, Oral|T121|T129|NON|NRW|NLM (2013)|111213|abbcdef
ENTRY = Special Supplemental Nutrition Program for Women, Infants, and Children (U.S.)|T057|NON|NRW|NLM (2017)|160628|abcdef
ENTRY = Women, Infants, and Children Program|T057|NON|NRW|NLM (2017)|160602|abcdef
ENTRY = Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction|T047|NON|NRW|ORD (2010)|130610|abcdef
ENTRY = 2-Enoyl-CoA Hydratase, 3-Hydroxyacyl-CoA Dehydrogenase-delta 3, delta 2-Enoyl-CoA Isomerase|T116|T126|NON|EQV|NLM (2014)|130130|abbcdef
ENTRY = 3-alpha,7-alpha,12-alpha-Trihydroxy-5-beta-Cholest-24-enoyl-CoA Hydratase|T116|T126|NON|EQV|NLM (2014)|121129|abbcdef
ENTRY = PtdIns(3,4,5)P3-Dependent Protein Kinase-1|T116|T126|NON|NRW|NLM (2014)|130226|abbcdef
ENTRY = Selenic Acid, Disodium Salt, 75Se-Labeled|T130|T197|NON|NRW|NLM (2014)|130418|abbcdef
ENTRY = Selenic Acid, Disodium Salt, Decahydrate|T121|T131|T197|NON|NRW|NLM (2014)|130329|abbbcdef
ENTRY = Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 11|T116|T123|NON|NRW|NLM (2014)|130404|abbcdef
ENTRY = Razoxane, (S)-Isomer, Hydrochloride|T109|T121|NON|NRW|NLM (2014)|130412|abbcdef
ENTRY = 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole|T109|T121|NON|EQV|NLM (2014)|130416|abbcdef
ENTRY = 2-((R)-((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole|T109|T121|NON|EQV|NLM (2014)|130416|abbcdef
ENTRY = 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt|T109|T121|NON|NRW|NLM (2014)|130417|abbcdef
ENTRY = Pulmonary Hypertension, Primary, 1|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Pulmonary Hypertension, Primary, Dexfenfluramine-Associated|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Pulmonary Hypertension, Primary, Fenfluramine-Associated|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cytochrome P450, Family 1, Subfamily B, Polypeptide 1|T116|T126|NON|EQV|NLM (2015)|140107|abbcdef
ENTRY = Cytochrome P450, Family 2, Subfamily A, Polypeptide 6|T116|T126|NON|EQV|NLM (2015)|140117|abbcdef
ENTRY = Porencephaly, Type 1, Autosomal Dominant|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cytochrome P450, Family 2, Subfamily C, Polypeptide 8|T116|T126|NON|EQV|NLM (2015)|140117|abbcdef
